10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549 

 ________________________________________________

FORM 10-Q

 ________________________________________________

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended January 31, 2024

OR 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from            to            

Commission File Number 1-33913

  ________________________________________________

 QUANEX BUILDING PRODUCTS CORPORATION

(Exact name of registrant as specified in its charter)

  ________________________________________________ 

Delaware	26-1561397
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

945 Bunker Hill Road, Suite 900, Houston, Texas 77024

(Address of principal executive offices and zip code)

Registrant’s telephone number, including area code: (713) 961-4600

  ________________________________________________

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.01 per share	NX	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (Section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☒    No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐  (Do not check if a smaller reporting company)	Smaller reporting company	☐
		Emerging growth company	☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Securities Act.			☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ☐    No ☒

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

The number of shares outstanding of the registrant's Common Stock as of February 29, 2024 was 33,103,593.

QUANEX BUILDING PRODUCTS CORPORATION

INDEX

PART I.	FINANCIAL INFORMATION	1
Item 1:	Financial Statements (Unaudited)	1
	Condensed Consolidated Balance Sheets – January 31, 2024 and October 31, 2023	1
	Condensed Consolidated Statements of Income – Three Months Ended January 31, 2024 and 2023	2
	Condensed Consolidated Statements of Comprehensive Income – Three Months Ended January 31, 2024 and 2023	3
	Condensed Consolidated Statements of Cash Flows – Three Months Ended January 31, 2024 and 2023	4
	Condensed Consolidated Statement of Stockholders’ Equity – Three Months Ended January 31, 2024 and 2023	5
	Notes to Unaudited Condensed Consolidated Financial Statements	6
Item 2:	Management’s Discussion and Analysis of Financial Condition and Results of Operations	21
Item 3:	Quantitative and Qualitative Disclosures About Market Risk	28
Item 4:	Controls and Procedures	29
PART II.	OTHER INFORMATION	30
Item 5:	Other Information	30
Item 6:	Exhibits	30

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

QUANEX BUILDING PRODUCTS CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited) 

	January 31, 2024		October 31, 2023
	(In thousands, except share  amounts)
ASSETS
Current assets:
Cash and cash equivalents	$	44,422	$	58,474
Accounts receivable, net of allowance for credit losses of $986 and $843	80,063		97,311
Inventories	107,478		97,959
Income taxes receivable	7,642		8,298
Prepaid and other current assets	13,390		11,558
Total current assets	252,995		273,600
Property, plant and equipment, net of accumulated depreciation of $375,560 and $368,763	253,681		250,664
Operating lease right-of-use assets	46,370		46,620
Goodwill	185,439		182,956
Intangible assets, net	72,008		74,115
Other assets	2,927		3,188
Total assets	$	813,420	$	831,143
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable	$	55,106	$	74,371
Accrued liabilities	46,478		50,319
Income taxes payable	—		384
Current maturities of long-term debt	2,500		2,365
Current operating lease liabilities	7,370		7,224
Total current liabilities	111,454		134,663
Long-term debt	61,594		66,435
Noncurrent operating lease liabilities	40,084		40,361
Deferred income taxes	30,737		29,133
Other liabilities	14,522		14,997
Total liabilities	258,391		285,589
Commitments and contingencies
Stockholders’ equity:
Preferred stock, no par value, shares authorized 1,000,000; issued and outstanding - none	—		—
Common stock, $0.01 par value, shares authorized 125,000,000; issued 37,127,024 and 37,176,958, respectively; outstanding 33,103,593 and 33,011,119, respectively	371		372
Additional paid-in-capital	248,715		251,576
Retained earnings	412,922		409,318
Accumulated other comprehensive loss	(32,060)		(38,141)
Less: Treasury stock at cost, 4,023,431 and 4,165,839 shares, respectively	(74,919)		(77,571)
Total stockholders’ equity	555,029		545,554
Total liabilities and stockholders' equity	$	813,420	$	831,143

The accompanying notes are an integral part of the financial statements.

1

QUANEX BUILDING PRODUCTS CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(Unaudited)

	Three Months Ended
	January 31,
	2024		2023
	(In thousands, except per share amounts)
Net sales	$	239,155	$	261,916
Cost and expenses:
Cost of sales (excluding depreciation and amortization)	187,723		210,149
Selling, general and administrative	32,363		36,744
Depreciation and amortization	11,152		10,620
Operating income	7,917		4,403
Non-operating (expense) income:
Interest expense	(1,068)		(2,259)
Other, net	1,042		218
Income before income taxes	7,891		2,362
Income tax expense	(1,642)		(453)
Net income	$	6,249	$	1,909
Basic earnings per common share	$	0.19	$	0.06
Diluted earnings per common share	$	0.19	$	0.06
Weighted-average common shares outstanding:
Basic	32,825		32,951
Diluted	33,043		33,137
Cash dividends per share	$	0.08	$	0.08

The accompanying notes are an integral part of the financial statements.

2

QUANEX BUILDING PRODUCTS CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(Unaudited)

	Three Months Ended
	January 31,
	2024		2023
	(In thousands)
Net income	$	6,249	$	1,909
Other comprehensive income:
Foreign currency translation gain	6,081		11,372
Other comprehensive income	6,081		11,372
Comprehensive income	$	12,330	$	13,281

The accompanying notes are an integral part of the financial statements.

3

QUANEX BUILDING PRODUCTS CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

	Three Months Ended
	January 31,
	2024		2023
	(In thousands)
Operating activities:
Net income	$	6,249	$	1,909
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization	11,152		10,620
Stock-based compensation	583		679
Deferred income tax	1,136		179
Other, net	1,790		1,509
Changes in assets and liabilities:
Decrease in accounts receivable	18,147		20,502
(Increase) decrease in inventory	(8,756)		645
Increase in other current assets	(1,680)		(1,431)
Decrease in accounts payable	(19,044)		(21,379)
Decrease in accrued liabilities	(7,181)		(12,686)
Increase in income taxes payable	264		536
Increase in deferred pension benefits	—		7
Increase in other long-term liabilities	852		1,461
Other, net	342		584
Cash provided by operating activities	3,854		3,135
Investing activities:
Business acquisition	—		(92,000)
Capital expenditures	(9,580)		(7,582)
Proceeds from disposition of capital assets	31		98
Cash used for investing activities	(9,549)		(99,484)
Financing activities:
Borrowings under credit facilities	—		102,000
Repayments of credit facility borrowings	(5,000)		(15,000)
Repayments of other long-term debt	(679)		(579)
Common stock dividends paid	(2,645)		(2,661)
Issuance of common stock	400		99
Payroll tax paid to settle shares forfeited upon vesting of stock	(1,193)		(545)
Cash (used for) provided by financing activities	(9,117)		83,314
Effect of exchange rate changes on cash and cash equivalents	760		997
Decrease in cash and cash equivalents	(14,052)		(12,038)
Cash and cash equivalents at beginning of period	58,474		55,093
Cash and cash equivalents at end of period	$	44,422	$	43,055

The accompanying notes are an integral part of the financial statements.

4

QUANEX BUILDING PRODUCTS CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(Unaudited)

Three Months Ended January 31, 2024	Common Stock		Additional Paid-in Capital		Retained Earnings		Accumulated Other Comprehensive Loss		Treasury Stock		Total Stockholders’ Equity
	(In thousands, no per share amounts shown except in verbiage)
Balance at October 31, 2023	$	372	$	251,576	$	409,318	$	(38,141)	$	(77,571)	$	545,554
Net income	—		—		6,249		—		—		6,249
Foreign currency translation adjustment	—		—		—		6,081		—		6,081
Common dividends ($0.08 per share)	—		—		(2,645)		—		—		(2,645)
Stock-based compensation activity:
Expense related to stock-based compensation	—		583				—		—		583
Stock options exercised	—		22		—		—		378		400
Restricted stock awards granted	—		(1,357)		—		—		1,357		—
Performance restricted stock units vested	—		(917)		—		—		917		—
Other	(1)		(1,192)		—		—		—		(1,193)
Balance at January 31, 2024	$	371	$	248,715	$	412,922	$	(32,060)	$	(74,919)	$	555,029
Three Months Ended January 31, 2023	Common Stock		Additional Paid-in Capital		Retained Earnings		Accumulated Other Comprehensive Loss		Treasury Stock		Total Stockholders’ Equity
	(In thousands, no per share amounts shown except in verbiage)
Balance at October 31, 2022	$	372	$	251,947	$	337,456	$	(49,422)	$	(75,518)	$	464,835
Net income	—		—		1,909		—		—		1,909
Foreign currency translation adjustment	—		—		—		11,372		—		11,372
Common dividends ($0.08 per share)	—		—		(2,661)		—		—		(2,661)
Stock-based compensation activity:
Expense related to stock-based compensation	—		679		—		—		—		679
Stock options exercised	—		6		—		—		93		99
Restricted stock awards granted	—		(1,752)		—		—		1,752		—
Performance restricted stock units vested	—		(605)		—		—		605		—
Other	—		(545)		—		—		—		(545)
Balance at January 31, 2023	$	372	$	249,730	$	336,704	$	(38,050)	$	(73,068)	$	475,688

The accompanying notes are an integral part of the financial statements.

5

QUANEX BUILDING PRODUCTS CORPORATION

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

1. Nature of Operations and Basis of Presentation

Quanex Building Products Corporation is a global, publicly traded manufacturing company primarily serving original equipment manufacturers (OEMs) in the fenestration, cabinetry, solar, refrigeration and outdoor products markets. These components can be categorized as window and door (fenestration) components and kitchen and bath cabinet components. Examples of fenestration components include: (1) energy-efficient flexible insulating glass spacers, (2) extruded vinyl profiles, (3) window and door screens, and (4) precision-formed metal and wood products. We also manufacture cabinet doors and other components for OEMs in the kitchen and bathroom cabinet industry. In addition, we provide certain other non-fenestration components and products, which include custom mixing, solar panel sealants, trim moldings, vinyl decking, vinyl fencing, customized compounds, water retention barriers, and conservatory roof components. We have organized our business into three reportable business segments. For additional discussion of our reportable business segments, see Note 11, “Segment Information.” We use low-cost, short lead-time production processes and engineering expertise to provide our customers with specialized products for their specific window, door, and cabinet applications. We believe these capabilities provide us with unique competitive advantages. We serve a primary customer base in North America and the United Kingdom (U.K.), and also serve customers in international markets through our operating plants in the U.K. and Germany, as well as through sales and marketing efforts in other countries.

Unless the context indicates otherwise, references to “Quanex”, the “Company”, “we”, “us” and “our” refer to the consolidated business operations of Quanex Building Products Corporation and its subsidiaries.

Basis of Presentation and Principles of Consolidation

The accompanying interim unaudited condensed consolidated financial statements include the accounts of Quanex Building Products Corporation. All intercompany accounts and transactions have been eliminated in consolidation. These financial statements have been prepared by us, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) have been condensed or omitted pursuant to such rules and regulations. The condensed consolidated balance sheet as of October 31, 2023 was derived from audited financial information but does not include all disclosures required by U.S. GAAP. The accompanying financial statements should be read in conjunction with the audited consolidated financial statements and the notes thereto, included in our Annual Report on Form 10-K for the fiscal year ended October 31, 2023. In our opinion, the accompanying financial statements contain all adjustments (which consist of normal recurring adjustments, except as disclosed herein) necessary to fairly present our financial position, results of operations and cash flows for the interim periods. The results of operations for the periods presented are not necessarily indicative of the results to be expected for the full year or for any future periods.

Use of Estimates

In preparing financial statements, we make informed judgments and estimates that affect the reported amounts of assets and liabilities as of the date of the financial statements and affect the reported amounts of revenues and expenses during the reporting period. We review our estimates on an on-going basis, including those related to impairment of long-lived assets and goodwill, contingencies and income taxes. Changes in facts and circumstances may result in revised estimates and actual results may differ from these estimates.

Revenue from Contracts with Customers

Revenue recognition

We recognize revenue that reflects the consideration we expect to receive for product sales upon transfer to customers. Revenue for product sales is recognized when control of the promised products is transferred to our customers, and we are entitled to consideration in exchange for such transfer. We account for a contract when a customer provides us with a firm purchase order that identifies the products to be provided, the payment terms for those products, and when collectability of the consideration due is probable.

Performance obligations

A performance obligation is a promise to provide the customer with a good or service. Our performance obligations include product sales, with each product included in a customer contract being recognized as a separate performance obligation.

6

QUANEX BUILDING PRODUCTS CORPORATION

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)

For contracts with multiple performance obligations, the standalone selling price of each product is generally readily observable.

Revenue from product sales is recognized at a point in time when the product is transferred to the customer, in accordance with the shipping terms, which is generally upon shipment. We estimate a provision for sales returns and warranty allowances to account for product returns related to general returns and product nonconformance.

We generally expense incremental costs of obtaining a contract when incurred because the amortization period would be less than one year. Additionally, we do not disclose the value of unsatisfied performance obligations for contracts with an original expected length of one year or less.

Pricing and sales incentives

Pricing is established at or prior to the time of sale with our customers and we record sales at the agreed-upon net selling price, reflective of current and prospective discounts.

Shipping and handling costs

We account for shipping and handling services as fulfillment services; accordingly, freight revenue is combined with the product deliverable rather than being accounted for as a distinct performance obligation within the terms of the agreement. Shipping and handling costs incurred by us for the delivery of goods to customers are considered a cost to fulfill the contract and are included in cost of sales in the accompanying condensed consolidated statements of income.

Contract assets and liabilities

Deferred revenue, which is not significant, is recorded when we have remaining unsatisfied performance obligations for which we have received consideration.

Disaggregation of revenue

We produce a wide variety of products that are used in the fenestration industry, including window spacer systems; extruded vinyl products; metal fabricated products; and astragals, thresholds and screens. In addition, we produce certain non-fenestration products, including kitchen and bath cabinet doors and components, flooring and trim moldings, solar edge tape, plastic decking, fencing, water retention barriers, conservatory roof components, and other products.

7

QUANEX BUILDING PRODUCTS CORPORATION

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)

The following table summarizes our product sales for the three months ended January 31, 2024 and 2023 into groupings by segment which we believe depicts how the nature, amount, timing and uncertainty of our revenues and cash flows are affected by economic factors. For further details regarding our results by segment, refer to Note 11, “Segment Information.”

	Three Months Ended
	January 31,
	2024		2023
	(In thousands)
North American Fenestration:
United States - fenestration	$	111,634	$	120,767
International - fenestration	6,144		5,127
United States - non-fenestration	25,791		23,066
International - non-fenestration	4,426		4,020
	$	147,995	$	152,980
European Fenestration:
International - fenestration	$	41,751	$	42,354
International - non-fenestration	7,686		12,598
	$	49,437	$	54,952
North American Cabinet Components:
United States - fenestration	$	3,675	$	3,908
United States - non-fenestration	39,179		50,049
International - non-fenestration	283		717
	$	43,137	$	54,674
Unallocated Corporate & Other
Eliminations	$	(1,414)	$	(690)
	$	(1,414)	$	(690)
Net sales	$	239,155	$	261,916

Allowance for Credit Losses

We have established an allowance for credit losses to estimate the risk of losses, which represents an estimate of expected losses over the remaining contractual life of our receivables. The allowance is determined using two methods. The amounts calculated from each of these methods are combined to determine the total amount reserved. First, a specific reserve is established for individual accounts where information indicates the customers may have an inability to meet financial obligations. Second, a reserve is determined for all customers based on a range of percentages applied to aging categories. These percentages are based on historical collection rates, write-off experience, and forecasts of future economic conditions. Actual write-offs are charged against the allowance when collection efforts have been unsuccessful.

Related Parties

Net sales include transactions with a customer which is a related party with one of our non-employee directors for the three months ended January 31, 2024 and 2023 of approximately $0.2 million, respectively. We performed a review of these transactions, of which no single transaction or series of related transactions exceeded $120,000 in amount, and determined that these transactions were enacted independently of each other. We are not aware of any other related party transactions with any of our current non-employee directors or officers outside of their normal business functions or expected contractual duties.

8

QUANEX BUILDING PRODUCTS CORPORATION

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)

2. Acquisition

On November 1, 2022, we entered into an Asset Purchase Agreement (the “Purchase Agreement”) with LMI Custom Mixing, LLC (“LMI”) and the equity owners of LMI, Lauren International, Ltd. and Meteor-US-Beteiligungs GMBH. Under the Purchase Agreement, we acquired substantially all of the operating assets comprising LMI’s polymer mixing and rubber compound production business (collectively, the “Purchased Assets”) and also agreed to assume certain liabilities relating to the Purchased Assets (collectively, the “Acquisition”). As consideration for the Purchased Assets, we paid $91.3 million in cash utilizing funds borrowed under our Credit Facility. In connection with the Acquisition, we amended our existing finance lease with Lauren Real Estate Holding LLC for the purpose of adding an additional lease renewal option and increasing rental space by approximately 60,000 square feet of rental space which was added to the 313,595 square feet of rentable area located in Cambridge, Ohio.

3. Inventories

Inventories consisted of the following at January 31, 2024 and October 31, 2023 (in thousands):

	January 31, 2024		October 31, 2023
Raw materials	$	60,659	$	53,585
Finished goods and work in process	44,322		42,195
Supplies and other	2,497		2,179
Total	$	107,478	$	97,959

Fixed costs related to excess manufacturing capacity, if any, have been expensed in the period they were incurred and, therefore, are not capitalized into inventory.

4. Goodwill and Intangible Assets

Goodwill

The change in the carrying amount of goodwill for the three months ended January 31, 2024 was as follows (in thousands):

	Three Months Ended
	January 31, 2024
Beginning balance as of November 1, 2023	$	182,956
Foreign currency translation adjustment	2,483
Balance as of the end of the period	$	185,439

At our last annual test date, August 31, 2023, we evaluated the recoverability of goodwill at each of our five reporting units with goodwill balances and determined that our goodwill was not impaired. We evaluated for indicators of impairment for all reporting units during the three months ended January 31, 2024 and determined that there were no triggering events. For additional discussion of change in reporting units and a summary of the change in the carrying amount of goodwill by segment, see Note 11, “Segment Information.”

9

QUANEX BUILDING PRODUCTS CORPORATION

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)

Identifiable Intangible Assets

Amortizable intangible assets consisted of the following as of January 31, 2024 and October 31, 2023 (in thousands):

	January 31, 2024				October 31, 2023
	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization
Customer relationships	$	159,184	$	102,324	$	157,629	$	99,230
Trademarks and trade names	56,003		43,824		55,519		42,879
Patents and other technology	25,154		22,185		25,127		22,051
Total	$	240,341	$	168,333	$	238,275	$	164,160

We had aggregate amortization expense related to intangible assets for the three months ended January 31, 2024 of $3.2 million and $3.1 million for the comparable prior year period.

Estimated remaining amortization expense, assuming current intangible balances and no new acquisitions, for future fiscal years as of January 31, 2024 (in thousands):

	Estimated Amortization Expense
2024 (remaining nine months)	$	8,540
2025	10,355
2026	10,113
2027	10,114
2028	4,880
Thereafter	28,006
Total	$	72,008

5. Debt and Finance Lease Obligations

Long-term debt consisted of the following at January 31, 2024 and October 31, 2023 (in thousands):

	January 31, 2024		October 31, 2023
Revolving Credit Facility	$	10,000	$	15,000
Finance lease obligations and other	55,211		55,000
Unamortized deferred financing fees	(1,117)		(1,200)
Total debt	$	64,094	$	68,800
Less: Current maturities of long-term debt	2,500		2,365
Long-term debt	$	61,594	$	66,435

Revolving Credit Facility

On July 6, 2022, we entered into our Second Amended and Restated Credit Agreement (the “Credit Facility”) with Wells Fargo Securities, LLC, as Agent, Swingline Lender and Issuing Lender, and BofA Securities, Inc. serving as Syndication Agent. We capitalized $1.2 million of deferred financing fees related to the Credit Facility. This $325.0 million revolving credit facility has a five-year term, maturing on July 6, 2027, and replaces our previous credit facility. Our previous credit facility is more fully described in our Annual Report on Form 10-K for the fiscal year ended October 31, 2023.

Interest payments for the Credit Facility are calculated, at our election and depending upon the Consolidated Net Leverage Ratio, at a Base Rate (as defined within the Credit Facility) plus an applicable margin or at the same rate as Risk-Free Rate (“RFR”) Loans for domestic borrowings or Eurocurrency Rate Loans plus an applicable margin. In addition, we are subject to commitment fees for the unused portion of the Credit Facility.

10

QUANEX BUILDING PRODUCTS CORPORATION

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)

The applicable margin and commitment fees are outlined in the following table:

Pricing Level	Consolidated Net Leverage Ratio	Commitment Fee	Eurocurrency Rate Loans and RFR Loans	Base Rate Loans
I	Less than or equal to 1.50 to 1.00	0.150%	1.25%	0.25%
II	Greater than 1.50 to 1.00, but less than or equal to 2.25 to 1.00	0.175%	1.50%	0.50%
III	Greater than 2.25 to 1.00, but less than or equal to 3.00 to 1.00	0.200%	1.75%	0.75%
IV	Greater than 3.00 to 1.00	0.250%	2.00%	1.00%

In the event of default, outstanding borrowings would accrue interest at the Default Rate, as defined, whereby the obligations will bear interest at a per annum rate equal to 2% above the total per annum rate otherwise applicable.

The Credit Facility provides for incremental revolving credit commitments for a minimum principal amount of $10.0 million, up to an aggregate amount of $150.0 million or 100% of Consolidated EBITDA, subject to the lender's discretion to elect or decline the incremental increase. We can also borrow up to the lesser of $15.0 million or the revolving credit commitment, as defined, under a Swingline feature of the Credit Facility.

The Credit Facility contains a: (1) Consolidated Interest Coverage Ratio requirement whereby we must not permit the Consolidated Interest Coverage Ratio, as defined, to be less than 3.00 to 1.00, and (2) Consolidated Net Leverage Ratio requirement, whereby we must not permit the Consolidated Net Leverage Ratio, as defined, to be greater than 3.25 to 1.00.

In addition to maintaining these financial covenants, the Credit Facility also limits our ability to enter into certain business transactions, such as to incur indebtedness or liens, to acquire businesses or dispose of material assets, make restricted payments, pay dividends (limited to $25.0 million per year) and other transactions as further defined in the Credit Facility. Some of these limitations, however, do not take effect so long as Consolidated Net Leverage Ratio is less than or equal to 2.75 to 1.00 and available liquidity exceeds $25.0 million. Substantially all of our domestic assets, with the exception of real property, are used as collateral for the Credit Agreement.

As of January 31, 2024, we had $10.0 million of borrowings outstanding under the Credit Facility (reduced by unamortized debt issuance costs of $1.1 million), $5.1 million of outstanding letters of credit and $55.2 million outstanding primarily under finance leases and other debt. We had $309.9 million available for use under the Credit Facility at January 31, 2024. Outstanding borrowings under the Credit Facility accrue interest at 6.68% per annum. Our weighted-average borrowing rate for borrowings outstanding during the three months ended January 31, 2024 and 2023 was 6.69% and 5.43%, respectively. We were in compliance with our debt covenants as of January 31, 2024.

11

QUANEX BUILDING PRODUCTS CORPORATION

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)

6. Retirement Plans

Pension Plan

Our non-contributory, single employer defined benefit pension plan covered certain of our employees in the U.S. During the year ended October 31. 2023, we terminated our defined contribution plan and settled the obligation during the three months ended October 31, 2023. The net periodic pension (benefit) cost for this plan for the three months ended January 31, 2024 and 2023 was as follows (in thousands):

	Three Months Ended
	January 31,
	2024		2023
Service cost	$	—	$	96
Interest cost	—		390
Expected return on plan assets	—		(366)
Amortization of net loss	—		10
Settlement reimbursement	(765)		—
Net periodic pension (benefit) cost	$	(765)	$	130

Other Plans

We also have a supplemental benefit plan covering certain executive officers and key employees and a non-qualified deferred compensation plan covering members of the Board of Directors and certain key employees. As of January 31, 2024 and October 31, 2023, our liability under the supplemental benefit plan was approximately $2.0 million. During the year ended October 31, 2023, the supplemental benefit plan was terminated. Benefits associated with this plan will be distributed in June 2024 in accordance with Internal Revenue Service regulations. As of January 31, 2024 and October 31, 2023, the liability associated with the deferred compensation plan was approximately $4.5 million and $3.9 million, respectively. We record the current portion of liabilities associated with these plans under the caption “Accrued liabilities,” and the long-term portion under the caption “Other liabilities” in the accompanying condensed consolidated balance sheets.

7. Income Taxes

To determine our income tax expense or benefit for interim periods, consistent with accounting standards, we apply the estimated annual effective income tax rate to year-to-date results, plus any applicable discrete items, which are recorded in the period in which they occur. Discrete items include, among others, such events as changes in estimates due to the finalization of tax returns, tax audit settlements, expiration of statutes of limitations, tax benefits on equity compensation, and increase or decrease in valuation allowances on deferred tax assets. Our annual effective tax rates from continuing operations for the three months ended January 31, 2024 and 2023 were 20.8% and 19.2%, respectively. The difference between our effective income tax rate and the U.S. federal statutory rate of 21% principally results from discrete tax items, U.S. state tax, non-U.S. tax rate differential and other permanent differences. The primary discrete items affecting the 2024 effective rate were the benefit of $0.4 million related to the vesting or exercise of equity-based compensation awards, and a charge of $0.6 million related to the true up of the deferred tax rate. The primary discrete item affecting the 2023 effective rate was a benefit of $0.2 million related to foreign entities true up.

As of January 31, 2024, our liability for uncertain tax positions (UTP) of $0.3 million relates to certain U.S. federal and state tax items regarding the interpretation of tax laws and regulations, including a minimal amount of interest and penalties. We include all interest and penalties related to uncertain tax benefits within our income tax provision account. To the extent interest and penalties are not assessed with respect to uncertain tax positions or the uncertainty of deductions in the future, amounts accrued will be reduced and reflected as a reduction of the overall income tax provision.

We evaluate the likelihood of realization of our deferred tax assets by considering both positive and negative evidence. We maintain a valuation allowance for certain state net operating losses which totaled $0.6 million as of January 31, 2024 and October 31, 2023, respectively.

12

QUANEX BUILDING PRODUCTS CORPORATION

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)

8. Contingencies

Remediation and Environmental Compliance Costs

Under applicable state and federal laws, we may be responsible for, among other things, all or part of the costs required to remove or remediate wastes or hazardous substances at locations we, or our predecessors, have owned or operated. From time to time, we also have been alleged to be liable for all or part of the costs incurred to clean up third-party sites where there might have been an alleged improper disposal of hazardous substances. Currently, we are not involved in any such matters.

From time to time, we incur routine expenses and capital expenditures associated with compliance with existing environmental regulations, including control of air emissions and water discharges, and plant decommissioning costs. We have not incurred any material expenses or capital expenditures related to environmental matters during the past three fiscal years, and do not expect to incur a material amount of such costs in fiscal 2024. While we will continue to have future expenditures related to environmental matters, any such amounts are impossible to reasonably estimate at this time. Based upon our experience to date, we do not believe that our compliance with environmental requirements will have a material adverse effect on our operations, financial condition or cash flows.

Litigation

From time to time, we, along with our subsidiaries, are involved in various litigation matters arising in the ordinary course of our business, including those arising from or related to contractual matters, commercial disputes, intellectual property, personal injury, environmental matters, product performance or warranties, product liability, insurance coverage and personnel and employment disputes. We regularly review with legal counsel the status of all ongoing proceedings, and we maintain insurance against these risks to the extent deemed prudent by our management and to the extent such insurance is available. However, there is no assurance that we will prevail in these matters or that our insurers will accept full coverage of these matters, and we could, in the future, incur judgments, enter into settlements of claims, or revise our expectations regarding the outcome or insurability of matters we face, which could materially impact our results of operations.

We have been and are currently party to multiple claims, some of which are in litigation, relating to alleged defects in a commercial sealant product that was manufactured and sold during the 2000’s. While we believe that our product was not defective and that we would prevail in these commercial sealant product claims if taken to trial, the timing, ultimate resolution and potential impact of these claims is not currently determinable. Nevertheless, after taking into account all currently available information, including our defenses, the advice of our counsel, and the extent and currently-expected availability of our existing insurance coverage, we believe that the eventual outcome of these commercial sealant claims will not have a material adverse effect on our overall financial condition, results of operations or cash flows, and we have not recorded any accrual with regard to these claims.

9. Fair Value Measurement of Assets and Liabilities

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value hierarchy distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity's own assumptions about market data developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to Level 1 and the lowest priority to Level 3. The three levels of the fair value hierarchy are described below:

•Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.

•Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability either directly or indirectly including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates) and inputs that are derived principally from or corroborated by observable market data by correlation or other means.

•Level 3 - Inputs that are both significant to the fair value measurement and unobservable.

Carrying amounts reported on the balance sheet for cash, cash equivalents, accounts receivable and accounts payable approximate fair value due to the short-term maturity of these instruments. Our outstanding debt is variable rate debt that re-prices frequently, thereby limiting our exposure to significant change in interest rate risk. As a result, the fair value of our debt instrument approximates carrying value at January 31, 2024, and October 31, 2023 (Level 2 measurement).

13

QUANEX BUILDING PRODUCTS CORPORATION

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)

Our performance share awards are marked-to-market on a quarterly basis during a three-year vesting period based on market data (Level 2 measurement). For further information, refer to Note 10, “Stock-Based Compensation - Performance Share Awards.”

We used recognized valuation techniques to determine the preliminary fair value of the assets and liabilities, including the excess earnings method for customer relationships and relief from royalty method for trade names and other technology with a discount rate that reflects the risk of the expected future cash flows (Level 3 measurement). For further information, refer to Note 2, “Acquisition.”

10. Stock-Based Compensation

We have established and maintain an Omnibus Incentive Plan (2020 Plan) that provides for the granting of restricted stock awards, stock options, restricted stock units, performance share awards, performance restricted stock units, and other stock-based and cash-based awards. The 2020 Plan is administered by the Compensation and Management Development Committee of the Board of Directors.

The aggregate number of shares of common stock authorized for grant under the 2020 Plan is 3,139,895 as approved by shareholders. Any officer, key employee and/or non-employee director is eligible for awards under the 2020 Plan. We grant restricted stock units to non-employee directors on the first business day of each fiscal year. As approved by the Compensation & Management Development Committee of our Board of Directors annually, we grant a mix of restricted stock awards, performance shares and performance restricted stock units to officers, management and key employees. We also historically granted stock options to certain officers, directors and key employees. Occasionally, we may make additional grants to key employees at other times during the year.

Restricted Stock Awards

Restricted stock awards are granted to key employees and officers annually, and typically cliff vest over a three-year period with service and continued employment as the only vesting criteria. The recipient of the restricted stock award is entitled to all of the rights of a shareholder, except that the award is nontransferable during the vesting period and quarterly dividends are not paid until the award vests. The fair value of the restricted stock award is established on the grant date and then expensed over the vesting period resulting in an increase in additional paid-in-capital. Shares are generally issued from treasury stock at the time of grant.

A summary of non-vested restricted stock awards activity during the three months ended January 31, 2024 is presented below:

	Restricted Stock Awards	Weighted-Average Grant Date Fair Value per Share
Non-vested at October 31, 2023	242,300	$	22.36
Granted	72,900	32.15
Forfeited	(11,800)	22.30
Vested	(66,600)	20.68
Non-vested at January 31, 2024	236,800	$	25.85

The total weighted-average grant-date fair value of restricted stock awards that vested during each of the three months ended January 31, 2024 and 2023 was $1.4 million and $0.9 million, respectively. As of January 31, 2024, total unrecognized compensation cost related to unamortized restricted stock awards was $4.0 million. We expect to recognize this expense over the remaining weighted-average vesting period of 2.3 years.

Stock Options

Historically, stock options have been awarded to key employees, officers and non-employee directors. In December 2017, the Compensation & Management Development Committee of the Board of Directors approved a change to the long-term incentive award program eliminating the grant of stock options and replacing this award with a grant of performance restricted stock units and performance shares as further described below. As a result, the final stock options were granted during the fiscal year ended October 31, 2017. Stock options typically vested ratably over a three-year period with service and continued employment as the vesting conditions. Our stock options may be exercised up to a maximum of ten years from the date of grant. The fair value of the stock options was determined on the grant date and expensed over the vesting period resulting in an

14

QUANEX BUILDING PRODUCTS CORPORATION

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)

increase in additional paid-in-capital. For employees who were nearing retirement-eligibility, we recognize stock option expense ratably over the shorter of the vesting period or the period from the grant-date to the retirement-eligibility date.

We use a Black-Scholes pricing model to estimate the fair value of stock options. A description of the methodology for the valuation assumptions was disclosed in our Annual Report on Form 10-K for the fiscal year ended October 31, 2023.

The following table summarizes our stock option activity for the three months ended January 31, 2024:

	Stock Options	Weighted-Average Exercise Price		Weighted-Average Remaining Contractual Term (in years)	Aggregate Intrinsic Value (000s)
Outstanding at October 31, 2023	107,530	$	19.48
Exercised	(20,280)	19.70
Outstanding at January 31, 2024	87,250	$	19.43	2.2	$	1,028
Vested at January 31, 2024	87,250	$	19.43	2.2	$	1,028
Exercisable at January 31, 2024	87,250	$	19.43	2.2	$	1,028

Intrinsic value is the amount by which the market price of the common stock on the date of exercise exceeds the exercise price of the stock option. The total intrinsic value of stock options exercised during the three months ended January 31, 2024 and 2023 was $0.2 million and less than $0.1 million, respectively.

Restricted Stock Units

Restricted stock units may be awarded to key employees and officers from time to time, and annually to non-employee directors. The non-employee director restricted stock units vest immediately but are payable only upon the director's cessation of service unless an election is made by the non-employee director to settle and pay the award on an earlier specified date. Restricted stock units awarded to employees and officers typically cliff vest after a three-year period with service and continued employment as the vesting conditions. Restricted stock units are not considered outstanding shares and do not have voting rights, although the holder does receive a cash payment equivalent to the dividend paid, on a one-for-one basis, on our outstanding common shares. Once the criteria is met, each restricted stock unit is payable to the holder in cash based on the market value of one share of our common stock. Accordingly, we record a liability for the restricted stock units on our balance sheet and recognize any changes in the market value during each reporting period as compensation expense.

During the three months ended January 31, 2024 and 2023, non-employee directors received 26,215 and 38,704 restricted stock units, respectively, at a weighted-average grant date fair value of $26.70 per share and $20.67 per share, respectively, which vested immediately. During the three months ended January 31, 2023, 21,774 restricted stock units, which were awarded to key employees, vested. During the three months ended January 31, 2024, we paid $0.1 million and $0.4 million for the comparable prior year to settle vested restricted stock units.

Performance Share Awards

We have awarded annual grants of performance shares to key employees and officers. Performance share awards vest with return on net assets (RONA) as the vesting condition and pay out 100% in cash, and are accounted for as liability.

The expected cash settlement of the performance share award is recorded as a liability and is being marked to market over the three-year term of the award and can fluctuate depending on the number of shares ultimately expected to vest. Depending on the achievement of the performance conditions, 0% to 200% of the awarded performance shares may ultimately vest.

The following table summarizes our performance share grants and the grant date fair value for the RONA performance metrics:

Grant Date	Shares Awarded	Grant Date Fair Value		Shares Forfeited
December 9, 2021	80,900	$	22.54	4,600
December 7, 2022	89,300	$	23.49	4,600
December 7, 2023	72,200	$	32.15	—

15

QUANEX BUILDING PRODUCTS CORPORATION

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)

In December 2023, 122,400 shares vested pursuant to the December 2020 grant, which were settled with a cash payment of $3.4 million.

Performance share awards are payable in cash based upon the number of performance shares ultimately earned, and are therefore not considered outstanding shares.

Performance Restricted Stock Units

We award performance restricted stock units to key employees and officers. These awards cliff vest upon a three-year service period with the absolute total shareholder return of our common stock over this three-year term as the vesting criteria. The number of shares earned is variable depending on the metric achieved, and the settlement method is 100% in our common stock, with accrued dividends paid in cash at the time of vesting, assuming the shares had been outstanding throughout the performance period.

To value the performance restricted stock units, we used a Monte Carlo simulation model to arrive at a grant-date fair value. This amount will be adjusted for forfeitures and expensed over the three-year term of the award with a credit to additional paid-in-capital. Depending on the achievement of the performance conditions, a minimum of 0% and a maximum of 150% of the awarded performance restricted stock units may vest. Specifically, the awards vest on a continuum with the following Absolute Total Shareholder Return (A-TSR) milestones:

Vesting Level	Vesting Criteria	Percentage of Award Vested
Level 1	A-TSR greater than or equal to 50%	150%
Level 2	A-TSR less than 50% and greater than or equal to 20%	100%
Level 3	A-TSR less than 20% and greater than or equal to -20%	50%
Level 4	A-TSR less than -20%	—%

The following table summarizes our performance restricted stock unit grants and the grant date fair value for the A-TSR performance metric:

Grant Date	Shares Awarded	Grant Date Fair Value		Shares Forfeited
December 9, 2021	50,900	$	21.06	3,400
December 7, 2022	51,500	$	23.22	3,100
December 7, 2023	40,700	$	30.35	—

During the three months ended January 31, 2024, 49,228 performance restricted stock units vested.

The performance restricted stock units are not considered outstanding shares, do not have voting rights, and are excluded from diluted weighted-average shares used to calculate earnings per share until the performance criteria is probable to result in the issuance of contingent shares. As of January 31, 2024, we have deemed 58,957 shares related to the December 2021 grant of performance restricted stock units as probable to vest.

16

QUANEX BUILDING PRODUCTS CORPORATION

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)

The following table summarizes amounts expensed as selling, general and administrative expense related to restricted stock awards, stock options, restricted stock units, performance share awards and performance restricted stock units for the three months ended January 31, 2024 and 2023 (in thousands):

	Three Months Ended
	January 31,
	2024		2023
Restricted stock awards	$	317	$	438
Restricted stock units	1,424		1,491
Performance share awards	569		2,639
Performance restricted stock units	266		241
Total compensation expense	$	2,576	$	4,809

Treasury Shares

We record treasury stock purchases under the cost method whereby the entire cost of the acquired stock is recorded as treasury stock. Shares are generally issued from treasury stock at the time of grant of restricted stock awards, upon the exercise of stock options, and upon the vesting of performance shares and performance restricted stock units. On the subsequent issuance of treasury shares, we record proceeds in excess of cost as an increase in additional paid in capital. A deficiency of such proceeds relative to costs would be applied to reduce paid-in-capital associated with prior issuances to the extent available, with the remainder recorded as a charge to retained earnings. There were no charges to retained earnings during the three months ended January 31, 2024.

The following table summarizes the treasury stock activity during the three months ended January 31, 2024:

	Three Months Ended
	January 31, 2024
Beginning Balance as of November 1, 2023	4,165,839
Restricted stock awards granted	(72,900)
Performance restricted stock units vested	(49,228)
Stock options exercised	(20,280)
Balance at January 31, 2024	4,023,431

11. Segment Information

We present three reportable business segments (1) NA Fenestration, comprising four operating segments primarily focused on the fenestration market in North America including vinyl profiles, insulating glass spacers, screens, custom compound mixing, and other fenestration components; (2) EU Fenestration, comprising our U.K.-based vinyl extrusion business, manufacturing vinyl profiles & conservatories, and the European insulating glass business manufacturing insulating glass spacers; and (3) NA Cabinet Components, comprising our cabinet door and components operations. Additionally, we maintain an Unallocated Corporate & Other which includes transaction expenses, stock-based compensation, long-term incentive awards based on the performance of our common stock and other factors, certain severance, legal, and other costs not deemed to be allocable to all segments, depreciation of corporate assets, interest expense, other, net, income taxes and inter-segment eliminations, and executive incentive compensation and medical expense fluctuations relative to planned costs as determined during the annual planning process. Other general and administrative costs associated with the corporate office are allocated to the reportable segments, based upon a relative measure of profitability in order to more accurately reflect each reportable business segment's administrative costs. We allocate corporate expenses to businesses acquired mid-year from the date of acquisition. The accounting policies of our operating segments are the same as those used to prepare the accompanying condensed consolidated financial statements. Corporate general and administrative expense allocated during the three month period ended January 31, 2024 was $7.3 million and $4.3 million for the comparable prior year period.

ASC Topic 280-10-50, “Segment Reporting” (ASC 280) permits aggregation of operating segments based on factors including, but not limited to: (1) similar nature of products serving the building products industry, primarily the fenestration business; (2) similar production processes, although there are some differences in the amount of automation amongst operating plants; (3) similar types or classes of customers, namely the primary OEMs; (4) similar distribution methods for product

17

QUANEX BUILDING PRODUCTS CORPORATION

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)

delivery, although the extent of the use of third-party distributors will vary amongst the businesses; (5) similar regulatory environment; and (6) converging long-term economic similarities.

Segment information for the three months ended January 31, 2024 and 2023, and total assets as of January 31, 2024 and October 31, 2023 are summarized in the following table (in thousands):

	NA Fenestration		EU Fenestration		NA Cabinet Components		Unallocated Corp. & Other		Total
Three Months Ended January 31, 2024
Net sales	$	147,995	$	49,437	$	43,137	$	(1,414)	$	239,155
Depreciation and amortization	5,475		2,558		3,065		54		11,152
Operating income (loss)	8,242		7,431		(3,797)		(3,959)		7,917
Capital expenditures	5,721		1,801		1,836		222		9,580
Three Months Ended January 31, 2023
Net sales	$	152,980	$	54,952	$	54,674	$	(690)	$	261,916
Depreciation and amortization	5,245		2,348		2,934		93		10,620
Operating income (loss)	9,723		7,396		(1,189)		(11,527)		4,403
Capital expenditures	3,613		1,956		1,860		153		7,582
As of January 31, 2024
Total assets	$	372,328	$	242,615	$	156,353	$	42,124	$	813,420
As of October 31, 2023
Total assets	$	379,286	$	239,333	$	158,824	$	53,700	$	831,143

The following table summarizes the change in the carrying amount of goodwill by reportable business segment for the three months ended January 31, 2024 (in thousands):

	NA Fenestration		EU Fenestration		NA Cabinet Comp.		Unallocated Corp. & Other		Total
Balance as of October 31, 2023	$	80,105	$	63,704	$	39,147	$	—	$	182,956
Foreign currency translation adjustment	—		2,483		—		—		2,483
Balance as of January 31, 2024	$	80,105	$	66,187	$	39,147	$	—	$	185,439

For further details of Goodwill, see Note 4, “Goodwill & Intangible Assets,” located herewith.

We did not allocate non-operating loss or income tax benefit to the reportable segments. The following table reconciles operating income as reported above to net income for the three months ended January 31, 2024 and 2023 (in thousands):

	Three Months Ended
	January 31,
	2024		2023
Operating income	$	7,917	$	4,403
Interest expense	(1,068)		(2,259)
Other, net	1,042		218
Income tax expense	(1,642)		(453)
Net income	$	6,249	$	1,909

12. Earnings Per Share

We compute basic earnings per share by dividing net income by the weighted-average number of common shares outstanding during the period. Diluted earnings per common and potential common shares include the weighted-average of additional shares associated with the incremental effect of dilutive employee stock options, non-vested restricted stock as

18

QUANEX BUILDING PRODUCTS CORPORATION

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)

determined using the treasury stock method prescribed by U.S. GAAP and contingent shares associated with performance share awards, if dilutive.

Basic and diluted earnings per share for the three months ended January 31, 2024 and 2023 were calculated as follows (in thousands, except per share data):

	Net Income		Weighted-Average Shares	Per Share
Three Months Ended January 31, 2024
Basic earnings per common share	$	6,249	32,825	$	0.19
Effect of dilutive securities:
Stock options	—		35	—
Restricted stock awards	—		124	—
Performance restricted stock units	—		59	—
Diluted earnings per common share	$	6,249	33,043	$	0.19
Three Months Ended January 31, 2023
Basic earnings per common share	$	1,909	32,951	$	0.06
Effect of dilutive securities:
Stock options	—		32	—
Restricted stock awards	—		111	—
Performance restricted stock units	—		43	—
Diluted earnings per common share	$	1,909	33,137	$	0.06

We do not include equity instruments in our calculation of diluted earnings per share if those instruments would be anti-dilutive. Such dilution is dependent on the excess of the market price of our stock over the exercise price and other components of the treasury stock method. There were no anti-dilutive instruments for the three months ended January 31, 2024 and 2023.

13. New Accounting Guidance

From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (“FASB”) or other standards setting bodies that we adopt as of the specified effective date. We did not adopt any new accounting pronouncements during the three months ended January 31, 2024.

Accounting Standards Not Yet Adopted

In November 2023, the FASB issued “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures,” which is intended to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024 with early adoption is permitted. The guidance is to be applied retrospectively to all prior periods presented in the financial statements. We are currently evaluating the potential impact of adopting this new guidance on our consolidated financial statements and related disclosures.

In December 2023, the FASB issued “Income Taxes (Topic 740): Improvements to Income Tax Disclosures,” which includes updates to the income tax disclosures related to the rate reconciliation and disaggregation of income taxes paid by jurisdiction. The amendments are effective for fiscal years beginning after December 15, 2024 with early adoption permitted. The amendments should be applied prospectively, however retrospective application is permitted. We are currently evaluating the potential impact of adopting this new guidance on our consolidated financial statements and related disclosures.

19

Unless the context indicates otherwise, references to “Quanex”, the “Company”, “we”, “us” and “our” refer to the consolidated business operations of Quanex Building Products Corporation and its subsidiaries.

Cautionary Note Regarding Forward-Looking Statements

Certain of the statements contained in this document and in documents incorporated by reference herein, including those made under the caption “Management’s Discussion and Analysis of Financial Condition and Results of Operations” are “forward-looking” statements as defined under the Private Securities Litigation Reform Act of 1995. Generally, the words “expect,” “believe,” “intend,” “estimate,” “anticipate,” “project,” “will” and similar expressions identify forward-looking statements, which generally are not historical in nature. Forward looking statements are (1) all statements which address future operating performance, (2) events or developments that we expect or anticipate will occur in the future, including statements relating to volume, sales, operating income and earnings per share, and (3) statements expressing general outlook about future operating results. Forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from our historical experience and our current projections or expectations. As and when made, we believe that these forward-looking statements are reasonable. However, caution should be taken not to place undue reliance on any such forward-looking statements since such statements speak only as of the date when made and there can be no assurance that such forward-looking statements will occur. We are not obligated to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Factors that could cause actual results to differ materially from those expressed or implied by the forward-looking statements include, but are not limited to the following:

•impacts from public health issues (including pandemics, such as the COVID-19 pandemic and quarantines) on the economy, demand for our products or our operations, including the responses of governmental authorities to contain such public health issues;

•changes in market conditions, particularly in the new home construction, and residential remodeling and replacement (R&R) activity markets in the United States, United Kingdom, Germany and elsewhere;

•changes in non-pass-through raw material costs;

•changes in domestic and international economic conditions;

•changes in availability and prices of raw material including inflationary pressures and supply chain challenges, which could be exacerbated by political or global unrest such as the current military conflicts in Ukraine and Gaza;

•our ability to attract and retain skilled labor;

•changes in purchases by our principal customers;

•fluctuations in foreign currency exchange rates;

•our ability to maintain an effective system of internal controls;

•our ability to successfully implement our internal operating plans and acquisition strategies;

•our ability to successfully implement our plans with respect to information technology (IT) systems and processes;

•our ability to control costs and increase profitability;

•changes in environmental laws and regulations;

•changes in warranty obligations;

•changes in energy costs and the availability of energy;

•changes in tax laws, and interpretations thereof;

•changes in interest rates;

•our ability to service our debt facilities and remain in good standing with our lenders;

•changes in the availability or applicability of our insurance coverage;

•our ability to maintain good relationships with our suppliers, subcontractors, and key customers; and

•the resolution of litigation and other legal proceedings.

For information on additional factors that could cause actual results to differ materially, please refer to the section entitled “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended October 31, 2023.

About Third-Party Information

In this report, we rely on and refer to information regarding industry data obtained from market research, publicly available information, industry publications, U.S. government sources and other third parties. Although we believe this information is reliable, we cannot guarantee the accuracy or completeness of the information and have not independently verified it.

20

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis should be read in conjunction with the accompanying unaudited condensed consolidated financial statements and related notes as of January 31, 2024, and for the three months ended January 31, 2024 and 2023, included elsewhere herein. For additional information pertaining to our business, including risk factors which should be considered before investing in our common stock, refer to our Annual Report on Form 10-K for the fiscal year ended October 31, 2023.

Our Business

We manufacture components for original equipment manufacturers (OEMs) in the building products industry. These components can be categorized as window and door (fenestration) components and kitchen and bath cabinet components. Examples of fenestration components include (1) energy-efficient flexible insulating glass spacers, (2) extruded vinyl profiles, (3) window and door screens, and (4) precision-formed metal and wood products. We also manufacture cabinet doors and other components for OEMs in the kitchen and bathroom cabinet industry. In addition, we provide certain other non-fenestration components and products, which include custom mixing, solar panel sealants, trim moldings, vinyl decking, vinyl fencing, customized compounds, water retention barriers, and conservatory roof components. We use low-cost, short lead-time production processes and engineering expertise to provide our customers with specialized products for their specific window, door, and cabinet applications. We believe these capabilities provide us with unique competitive advantages. We serve a primary customer base in North America and the U.K., and also serve customers in international markets through our operating plants in the U.K. and Germany, as well as through sales and marketing efforts in other countries.

We continue to invest in organic growth initiatives and we intend to continue evaluating business acquisitions that allow us to expand our existing fenestration and cabinet component footprint, enhance our product offerings, provide new complementary technology, enhance our leadership position within the markets we serve and expand into new markets or service lines. We have disposed of non-core businesses in the past, and continue to evaluate our business portfolio to ensure that we are investing in markets where we believe there is potential future growth.

We currently have three reportable business segments: (1) North American Fenestration segment (“NA Fenestration”), comprising four operating segments, manufacturing vinyl profiles, IG spacers, screens, custom compound mixing, and other fenestration components; (2) European Fenestration segment (“EU Fenestration”), comprising our U.K.-based vinyl extrusion business, manufacturing vinyl profiles and conservatories, and the European insulating glass business manufacturing IG spacers; and (3) North American Cabinet Components segment (“NA Cabinet Components”), comprising our North American cabinet door and components business and two wood-manufacturing plants. We maintain a grouping called Unallocated Corporate & Other, which includes transaction expenses, stock-based compensation, long-term incentive awards based on the performance of our common stock and other factors, certain severance, legal, and other costs not deemed to be allocable to all segments, depreciation of corporate assets, interest expense, other, net, income taxes and inter-segment eliminations, and executive incentive compensation and medical expense fluctuations relative to planned costs as determined during the annual planning process. Other corporate general and administrative costs have been allocated to the reportable business segments, based upon a relative measure of profitability in order to more accurately reflect each reportable business segment's administrative costs. We allocate corporate expenses to businesses acquired mid-year from the date of acquisition. The accounting policies of our operating segments are the same as those used to prepare our accompanying condensed consolidated financial statements.

Recent Transactions and Events

On November 1, 2022, we entered into an Asset Purchase Agreement with LMI and the equity owners of LMI, Lauren International, Ltd. and Meteor-US-Beteiligungs GMBH. Under the Purchase Agreement, we acquired substantially all of the operating assets comprising LMI’s polymer mixing and rubber compound production business and also agreed to assume certain liabilities relating to the Acquisition. As consideration for the Purchased Assets, we paid $91.3 million in cash utilizing funds borrowed under our Credit Facility. In connection with the Acquisition, we amended our existing finance lease with Lauren Real Estate Holding LLC for the purpose of adding an additional lease renewal option and increasing rental space by approximately 60,000 square feet of rental space which was added to the 313,595 square feet of rentable area located in Cambridge, Ohio.

U.S. and global markets are experiencing volatility and disruption following the escalation of geopolitical tensions and the military conflicts currently ongoing in Ukraine and Gaza. Although the length and impact of these ongoing military conflicts are highly unpredictable, the conflicts could lead to market or operational disruptions, including significant volatility in commodity prices, credit and capital markets, as well as supply chain interruptions. Russia, Europe’s largest provider of natural gas, has significantly reduced the export of natural gas compared to the beginning of the conflict resulting in the increase in natural gas prices and the potential for natural gas shortages. In addition, one of the suppliers of a vapor barrier used in the

21

production of our insulating glass spacers is located in Israel and may experience a disruption as a result of the ongoing conflict in Gaza. If these trends continues, this would not only negatively impact our European manufacturing facilities, this may also impact our customers and their demand for our products. We continue to monitor these situations and their impact on our business.

The conflicts in Ukraine and Gaza and their impacts on the global economy, including inflation and the price of raw materials, supply chain disruptions, and the volatility in interest rates including home mortgage rates, are unpredictable and there may be developments outside our control requiring us to adjust our operating plan.

Market Overview and Outlook

We believe the primary drivers of our operating results continue to be North American new home construction and residential remodeling and replacement (R&R) activity. We believe that housing starts and window shipments are indicators of activity levels in the homebuilding and window industries, and we use this data, as published by or derived from third-party sources, to evaluate the market. We have evaluated the market using data from the National Association of Homebuilders (NAHB) with regard to housing starts, and published reports by Ducker Worldwide, LLC (Ducker), a consulting and research firm, with regard to window shipments in the U.S. We obtain market data from Catalina Research, a consulting and research firm, for insight into the U.S. residential wood cabinet demand.

In February 2024, the NAHB forecasted calendar-year housing starts to be 1.4 million in the 2024 and 2025 calendar-years. In February 2024, the Ducker forecast indicated that total window shipments are expected to decrease 7.6% in calendar-year 2023 and 1.2% in 2024.

Several commodities in our business are subject to pricing fluctuations, including polyvinyl resin (PVC), titanium dioxide (TiO2), petroleum products, aluminum and wood. For the majority of our customers and critical suppliers, we have price adjusters in place which effectively share the impact of pass-through price changes for our primary commodities with our customers commensurate with the market at large. Our long-term exposure to these price fluctuations is somewhat mitigated due to the contractual component of the adjuster programs. However, these adjusters are not in place with all customers and for all commodities, and there is a level of exposure to such volatility due to the lag associated with the timing of price updates in accordance with our customer agreements, particularly with regard to hardwoods. In addition, some of these commodities are in high demand, particularly in Europe, which can affect the cost of the raw materials, a portion of which we may not be able to fully recover.

The global economy remains uncertain due to currency devaluations, political unrest, terror threats, global pandemics such as COVID-19, and even the political landscape in the U.S. These and other macro-economic factors have impacted the global financial markets, which may have contributed to significant changes in foreign currencies. We continue to monitor our exposure to changes in exchange rates.

22

Results of Operations

Three Months Ended January 31, 2024 Compared to Three Months Ended January 31, 2023

	Three Months Ended January 31,
	2024		2023		Change $		% Variance
	(Dollars in thousands)
Net sales	$	239,155	$	261,916	$	(22,761)	(9)	%
Cost of sales (excluding depreciation and amortization)	187,723		210,149		(22,426)		(11)	%
Selling, general and administrative	32,363		36,744		(4,381)		(12)	%
Depreciation and amortization	11,152		10,620		532		5	%
Operating income	7,917		4,403		3,514		80	%
Interest expense	(1,068)		(2,259)		1,191		(53)	%
Other, net	1,042		218		824		378	%
Income tax expense	(1,642)		(453)		(1,189)		262	%
Net income	$	6,249	$	1,909	$	4,340	227	%

Our period-over-period results by reportable segment follow.

Changes Related to Operating Income by Reportable Segment:

NA Fenestration

	Three Months Ended January 31,
	2024			2023			$ Change		% Variance
	(Dollars in thousands)
Net sales	$	147,995		$	152,980		$	(4,985)	(3)%
Cost of sales (excluding depreciation and amortization)	118,368			124,717			(6,349)		(5)%
Selling, general and administrative	15,910			13,295			2,615		20%
Depreciation and amortization	5,475			5,245			230		4%
Operating income	$	8,242		$	9,723		$	(1,481)	(15)%
Operating income margin	6		%	6		%

Net Sales. Net sales decreased $5.0 million, or 3%, for the three months ended January 31, 2024 compared to the same period in 2023, which was primarily driven by a $4.3 million decrease in volumes mainly due to softer market demand and a return to normal seasonality and a $0.7 million decrease in price and raw material surcharges.

Cost of Sales. The cost of sales decreased $6.3 million, or 5%, for the three months ended January 31, 2024 as compared to the same period in 2023. Cost of sales, including labor, decreased primarily due to lower volumes and deflation of raw materials during the period.

Selling, General and Administrative. Selling, general and administrative expenses increased $2.6 million, or 20%, for the three months ended January 31, 2024 as compared to the same period in 2023. The increase is primarily due to increases in labor costs year-over-year.

23

EU Fenestration

	Three Months Ended January 31,
	2024			2023			$ Change		Variance %
	(Dollars in thousands)
Net sales	$	49,437		$	54,952		$	(5,515)	(10)%
Cost of sales (excluding depreciation and amortization)	31,703			37,703			(6,000)		(16)%
Selling, general and administrative	7,745			7,505			240		3%
Depreciation and amortization	2,558			2,348			210		9%
Operating income	$	7,431		$	7,396		$	35	—%
Operating income margin	15		%	13		%

Net Sales. Net sales decreased $5.5 million, or 10%, comparing the three months ended January 31, 2024 to the same period in 2023, which was primarily driven by a $6.8 million decrease in volumes largely due to softer market demand and a return to normal seasonality, partially offset by $1.0 million of foreign currency rate change and $0.3 million of base price increases.

Cost of Sales. The cost of sales decreased $6.0 million, or 16%, for the three months ended January 31, 2024 compared to the same period in 2023. Cost of sales decreased primarily due to a decrease in volumes, deflation in the price of raw materials and foreign currency impacts.

Selling, General and Administrative. Selling, general and administrative expense increased $0.2 million, or 3%, for the three months ended January 31, 2024 compared to the same period in 2023. The increase is primarily due to increases in labor costs year-over-year.

NA Cabinet Components

	Three Months Ended January 31,
	2024			2023			$ Change		Variance %
	(Dollars in thousands)
Net sales	$	43,137		$	54,674		$	(11,537)	(21)%
Cost of sales (excluding depreciation and amortization)	38,743			48,056			(9,313)		(19)%
Selling, general and administrative	5,126			4,873			253		5%
Depreciation and amortization	3,065			2,934			131		4%
Operating loss	$	(3,797)		$	(1,189)		$	(2,608)	219%
Operating loss margin	(9)		%	(2)		%

Net Sales. Net sales decreased $11.5 million, or 21%, for the three months ended January 31, 2024 compared to the same period in 2023, which was driven by a $6.4 million decrease in volumes due to softer market demand driven by weaker consumer confidence and a $5.1 million decrease in raw material indexes.

Cost of Sales. Cost of sales decreased $9.3 million, or 19%, for the three months ended January 31, 2024 compared with the same period in 2023, primarily as a result of lower volumes year-over-year.

Selling, General and Administrative. Selling, general and administrative expense increased $0.3 million, or 5%, for the three months ended January 31, 2024 compared to the same period in 2023. This increase is primarily due to due to increases in labor costs year-over-year.

24

Unallocated Corporate & Other

	Three Months Ended January 31,
	2024		2023		$ Change		Variance %
	(Dollars in thousands)
Net sales	$	(1,414)	$	(690)	$	(724)	105%
Cost of sales (excluding depreciation and amortization)	(1,091)		(327)		(764)		234%
Selling, general and administrative	3,582		11,071		(7,489)		(68)%
Depreciation and amortization	54		93		(39)		(42)%
Operating loss	$	(3,959)	$	(11,527)	$	7,568	(66)%

Net Sales. Net sales for Unallocated Corporate & Other represents the elimination of inter-segment sales for the three months ended January 31, 2024 and 2023.

Cost of Sales. Cost of sales for Unallocated Corporate & Other consists of the elimination of inter-segment sales, profit in inventory, and other costs.

Selling, General and Administrative. Selling, general and administrative expenses decreased $7.5 million, or 68%, for the three months ended January 31, 2024 compared to the same period in 2023. This decrease is primarily attributable to a decrease in transaction fees and compensation expense including the valuations of our stock-based compensation awards during the three months ended January 31, 2024 as compared to the prior year period.

Changes related to Non-Operating Items:

Interest Expense. Interest expense decreased $1.2 million for the three months ended January 31, 2024 compared to the same period in 2023 primarily as a result of lower borrowings outstanding during the three months ended January 31, 2024 as compared to the prior year period.

Income Taxes. We recorded income tax expense of $1.6 million on pre-tax income of $7.9 million for the three months ended January 31, 2024, an effective rate of 20.8%, and income tax expense of $0.5 million on a pre-tax income of $2.4 million for the three months ended January 31, 2023, an effective rate of 19.2%. The increase in income tax expense year-over-year was primarily driven by the differences in discrete items.

Liquidity and Capital Resources

Overview

Historically, our principal sources of funds have been cash on hand, cash flow from operations, and borrowings under our credit facilities.

We maintain a $325.0 million revolving credit facility (the Credit Facility) that matures in 2027 (5-year term) and requires interest payments calculated at a variable market rate depending upon our Consolidated Net Leverage Ratio. The applicable rate during the three months ended January 31, 2024 was RFR Rate + 1.25%. Our cost of capital could increase depending upon the Consolidated Net Leverage Ratio at the end of any given quarter. In addition to the Consolidated Net Leverage Ratio covenant, we are required to meet a Consolidated Interest Coverage Ratio covenant, and there are limitations on certain transactions including our ability to incur indebtedness, incur liens, dispose of material assets, acquire businesses, make restricted payments and pay dividends (limited to $25.0 million per year). We are amortizing deferred financing fees of $1.1 million straight-line over the remaining term of the facility. For further details of the Credit Facility, refer to Note 5, “Debt and Finance Lease Obligations” to the accompanying unaudited condensed consolidated financial statements contained elsewhere herein.

As of January 31, 2024, we had $44.4 million of cash and equivalents, $10.0 million outstanding under the Credit Facility, $5.1 million of outstanding letters of credit and $55.2 million outstanding under finance leases and other debt. Of the $55.2 million outstanding under finance leases and other debt, $51.7 million relates to real estate leases. We had $309.9 million available for use under the Credit Facility at January 31, 2024.

During December 2021, our Board of Directors approved a stock repurchase program that authorized the repurchase of up to $75.0 million worth of shares of our common stock. Repurchases under the program will be made in open market transactions or privately negotiated transactions, subject to market conditions, applicable legal requirements and other relevant factors. During the three months ended January 31, 2024, we did not purchase any shares under this program and as of

25

January 31, 2024 we had a maximum of $62.8 million available to purchase shares under this program. The program does not have an expiration date or a limit on the number of shares that may be purchased.

We repatriated $3.6 million and $4.3 million of foreign cash during the three months ended January 31, 2024 and 2023, respectively. We expect to repatriate excess cash moving forward and use the funds to retire debt or meet current working capital needs. In the U.K., we insure against a portion of our credit losses. We believe our business model, our current cash reserves and our strong balance sheet leave us well-positioned to manage our business and remain in compliance with our debt covenants.

Analysis of Cash Flow

The following table summarizes our cash flow results for the three months ended January 31, 2024 and 2023:

	Three Months Ended
	January 31,
	2024		2023
	(Dollars in thousands)
Cash provided by operating activities	$	3,854	$	3,135
Cash used for investing activities	$	(9,549)	$	(99,484)
Cash (used for) provided by financing activities	$	(9,117)	$	83,314

Operating Activities. Cash provided by operating activities increased $0.7 million for the three months ended January 31, 2024 compared to the three months ended January 31, 2023. The increase in operating cash flows is primarily due to an increase net income year-over-year due to an improvement in gross margin efficiency and a decrease in transaction fees partially offset by unfavorable changes to working capital. The unfavorable changes in working capital were largely driven by an increase in inventory due to inventory build partially offset by a lower payout of accrued incentives.

Investing Activities. Cash used for investing activities decreased $89.9 million for the three months ended January 31, 2024 compared to the same period in 2023, primarily as a result of no business acquisitions in 2024 compared to the acquisition of LMI in 2023.

Financing Activities. Cash used for financing activities was $9.1 million for the three months ended January 31, 2024 compared to cash provided by financing activities of $83.3 million for the same period in 2023. The change in investing cash flows is primarily as a result of a decrease in net borrowings of long-term debt. During the three months ended January 31, 2023, $92.0 million of the borrowings of long-term debt was related to the acquisition of LMI.

Liquidity Requirements

Historically, our strategy for deploying cash has been to invest in organic growth opportunities, develop our infrastructure, and explore strategic acquisitions. Other uses of cash include paying cash dividends to our shareholders and repurchasing our common stock. During the three months ended January 31, 2024 and 2023, we repatriated $3.6 million and $4.3 million, respectively, of foreign earnings from our foreign locations. We maintain cash balances in foreign countries which total $17.5 million as of January 31, 2024.

Critical Accounting Policies and Estimates

The preparation of our financial statements in accordance with accounting principles generally accepted in the U.S. (U.S. GAAP) requires us to make estimates and assumptions that affect the reported amount of assets, liabilities, revenues and expenses and related disclosures of contingent assets and liabilities. Estimates and assumptions about future events and their effects cannot be perceived with certainty. Estimates may change as new events occur, as more experience is acquired, as additional information becomes available and as our operating environment changes. We base our estimates on historical experience and on various other assumptions that we believe are reasonable under the circumstances, and that we believe provide a basis for making judgments about the carrying value of assets and liabilities that are not readily available through open market quotes. We must use our judgment with regard to uncertainties in order to make these estimates. Actual results could differ from these estimates.

For a description of our critical accounting policies and estimates, see our Annual Report on Form 10-K for the fiscal year ended October 31, 2023. Our critical accounting policies and estimates have not changed materially during the three months ended January 31, 2024.

26

New Accounting Pronouncements

From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (“FASB”) or other standards setting bodies that we adopt as of the specified effective date. We did not adopt any new accounting pronouncements during the three months ended January 31, 2024.

Accounting Standards Not Yet Adopted

In November 2023, the FASB issued “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures,” which is intended to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024 with early adoption is permitted. The guidance is to be applied retrospectively to all prior periods presented in the financial statements. We are currently evaluating the potential impact of adopting this new guidance on our consolidated financial statements and related disclosures.

In December 2023, the FASB issued “Income Taxes (Topic 740): Improvements to Income Tax Disclosures,” which includes updates to the income tax disclosures related to the rate reconciliation and disaggregation of income taxes paid by jurisdiction. The guidance is effective for fiscal years beginning after December 15, 2024 with early adoption permitted. The amendments should be applied prospectively, however retrospective application is permitted. We are currently evaluating the potential impact of adopting this new guidance on our consolidated financial statements and related disclosures.

27

Item 3. Quantitative and Qualitative Disclosures About Market Risk

The following discussion of our exposure to various market risks contains “forward looking statements” regarding our estimates, assumptions and beliefs concerning our exposure. Although we believe these estimates and assumptions are reasonable in light of information currently available to us, we cannot provide assurance that these estimates will not materially differ from actual results due to the inherent unpredictability of interest rates, foreign currency rates and commodity prices as well as other factors. We do not use derivative financial instruments for speculative or trading purposes.

Interest Rate Risk

Our outstanding debt bears interest at variable rates and accordingly is sensitive to changes in interest rates. Based upon the balances of the variable rate debt at January 31, 2024, a hypothetical 1.0% increase or decrease in interest rates could result in approximately $0.1 million of additional pretax charges or credit to our net income per year. This sensitivity is impacted by the amount of borrowings under our credit facilities, and amounts outstanding under finance leases.

Foreign Currency Rate Risk

Our international operations have exposure to foreign currency rate risks, primarily due to fluctuations in the Euro, the British Pound Sterling and the Canadian Dollar. From time to time, we enter into foreign exchange contracts associated with our operations to manage a portion of the foreign currency rate risk. There were no corresponding foreign currency derivatives as of January 31, 2024 or October 31, 2023.

Commodity Price Risk

We purchase PVC as the significant raw material consumed in the manufacture of vinyl extrusions. We have resin adjusters in place with a majority of our customers and our resin supplier that is adjusted based upon published indices for lagging resin prices. These adjusters effectively share the base pass-through price changes of PVC with our customers commensurate with the market at large. Our long-term exposure to changes in PVC prices is somewhat mitigated due to the contractual component of the resin adjuster program. However, there is a level of exposure to short-term volatility due to timing lags.

We adjust the pricing of petroleum-based raw materials for the majority of our customers who purchase products using these materials. This is intended to offset the fluctuating cost of products which are highly correlated to the price of oil including butyl and other oil-based raw materials. This program is adjusted monthly based upon the 90-day average published price for Brent crude. The oil-based raw materials that we purchase are subject to similar pricing schemes. As such, our long-term exposure to increases in oil-based raw material prices is significantly reduced under this program.

Similarly, NA Cabinet Components includes a price index provision in the majority of its customer arrangements to insulate against significant fluctuations in the price for various hardwood products used as the primary raw material for kitchen and bathroom cabinet doors. Like our vinyl extrusion business, we are exposed to short-term volatility in wood prices due to a lag in the timing of price updates which generally could extend for up to three months.

We have begun implementing additional programs for other raw materials to facilitate more accurate pricing and reduce our exposure to changing material costs when necessary, however these are also subject to timing lags. While we maintain surcharges and other adjusters to manage our exposure to changes in the prices of our critical raw materials, we use several commodities in our business that are not covered by contractual surcharges or adjusters for which pricing can fluctuate, including PVC compound micro ingredients, silicone and other inputs. Further discussion of our industry risks is included within our Annual Report on Form 10-K for the fiscal year ended October 31, 2023.

28

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including the Chief Executive Officer and Chief Financial Officer, we have evaluated the effectiveness of our disclosure controls and procedures pursuant to Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (1934 Act) as of January 31, 2024. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that, as of January 31, 2024, the disclosure controls and procedures are effective.

Changes in Internal Control over Financial Reporting

There have been no changes in internal controls over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the 1934 Act) during the most recent fiscal quarter that have materially affected or are reasonably likely to materially affect our internal control over financial reporting.

29

PART II. OTHER INFORMATION

Item 5. Other Information

During the three months ended January 31, 2024, none of our directors or executive officers adopted or terminated any contract, instruction or written plan for the purchase or sale of our securities to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any “non-Rule 10b5-1 trading arrangement.”

Item 6. Exhibits

The exhibits required to be furnished pursuant to Item 6 are listed in the Exhibit Index filed herewith, which Exhibit Index is incorporated herein by reference.

30

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		QUANEX BUILDING PRODUCTS CORPORATION
Date:	March 8, 2024	/s/ Scott M. Zuehlke
		Scott M. Zuehlke
		Senior Vice President - Chief Financial Officer & Treasurer (Principal Financial Officer)

31

	EXHIBIT INDEX
Exhibit Number	Description of Exhibits
3.1	Restated Certificate of Incorporation of the Registrant dated as of March 4, 2016, filed as Exhibit 3.1 of the Registrant’s Current Report on Form 8-K (Reg. No. 001-33913) as filed with the Securities and Exchange Commission on March 7, 2016, and incorporated herein by reference.
3.2	Fourth Amended and Restated Bylaws of the Registrant dated as of February 27, 2020, filed as Exhibit 3.2 of the Registrant's Quarterly Report on Form 10-Q (Reg. No. 001-33913) for the quarter ended January 31, 2020, and incorporated herein by reference.
4.1	Form of Registrant’s Common Stock certificate, filed as Exhibit 4.1 of Amendment No. 1 to the Registrant’s Registration Statement on Form 10-Q (Reg. No. 001-33913) as filed with the Securities and Exchange Commission on February 14, 2008, and incorporated herein by reference.
4.2	Second Amended and Restated Credit Agreement dated as of July 6, 2022, by and among the Company; the lenders party thereto; and Wells Fargo Bank, National Association, as Agent; filed as Exhibit 10.1 of the Registrant's Current Report on Form 8-K (Reg. No. 001-33913) as filed with the Securities and Exchange Commission on July 6, 2022, and incorporated herein by reference.
*31.1	Certification by chief executive officer pursuant to Rule 13a-14(a)/15d-14(a).
*31.2	Certification by chief financial officer pursuant to Rule 13a-14(a)/15d-14(a).
*32.1	Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
*101.INS	XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
*101.SCH	XBRL Taxonomy Extension Schema Document
*101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document
*101.DEF	XBRL Taxonomy Extension Definition Linkbase Document
*101.LAB	XBRL Taxonomy Extension Label Linkbase Document
*101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document

* Filed herewith

As permitted by Item 601(b)(4)(iii)(A) of Regulation S-K, the Registrant has not filed with this Quarterly Report on Form 10-Q certain instruments defining the rights of holders of long-term debt of the Registrant and its subsidiaries because the total amount of securities authorized under any of such instruments does not exceed 10% of the total assets of the Registrant and its subsidiaries on a consolidated basis. The Registrant agrees to furnish a copy of any such agreements to the Securities and Exchange Commission upon request.

32

EX-31.1

Exhibit 31.1

CHIEF EXECUTIVE OFFICER CERTIFICATION

I, George L. Wilson, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Quanex Building Products Corporation (the “Registrant”);

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

4.The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures [as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)] and internal control over financial reporting [as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)] for the Registrant and have:

a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and

5.The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions):

a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

March 8, 2024

/s/ George L. Wilson

George L. Wilson
President and Chief Executive Officer
(Principal Executive Officer)

EX-31.2

Exhibit 31.2

CHIEF FINANCIAL OFFICER CERTIFICATION

I, Scott M. Zuehlke, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Quanex Building Products Corporation (the “Registrant”);

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

4.The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures [as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)] and internal control over financial reporting [as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)] for the Registrant and have:

a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and

5.The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions):

a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

March 8, 2024

/s/ Scott M. Zuehlke

Scott M. Zuehlke
Senior Vice President - Chief Financial Officer and Treasurer
(Principal Financial Officer)

EX-32.1

Exhibit 32.1

Certification Pursuant To Section 906 of the Sarbanes-Oxley Act of 2002

We hereby certify that the accompanying Quarterly Report on Form 10-Q of Quanex Building Products Corporation for the quarter ended January 31, 2024 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Report fairly presents, in all material respects, the financial condition and results of operations of Quanex Building Products Corporation.

March 8, 2024

/s/ George L. Wilson	/s/ Scott M. Zuehlke
George L. Wilson President andChief Executive Officer (Principal Executive Officer)	Scott M. Zuehlke Senior Vice President—Chief Financial Officer and Treasurer (Principal Financial Officer)

XML

Cover page - shares	3 Months Ended
	Jan. 31, 2024	Feb. 29, 2024
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jan. 31, 2024
Document Transition Report	false
Entity File Number	1-33913
Entity Registrant Name	QUANEX BUILDING PRODUCTS CORPORATION
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	26-1561397
Entity Address, Address Line One	945 Bunker Hill Road
Entity Address, Address Line Two	Suite 900
Entity Address, City or Town	Houston
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	77024
City Area Code	713
Local Phone Number	961-4600
Title of 12(b) Security	Common Stock, par value $0.01 per share
Trading Symbol	NX
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Central Index Key	0001423221
Current Fiscal Year End Date	--10-31
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q1
Amendment Flag	false
Entity Common Stock, Shares Outstanding		33,103,593

XML

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Jan. 31, 2024	Oct. 31, 2023
Current assets:
Cash and cash equivalents	$ 44,422	$ 58,474
Accounts receivable, net of allowance for credit losses of $986 and $843	80,063	97,311
Inventories	107,478	97,959
Income taxes receivable	7,642	8,298
Prepaid and other current assets	13,390	11,558
Total current assets	252,995	273,600
Property, plant and equipment, net of accumulated depreciation of $375,560 and $368,763	253,681	250,664
Operating lease right-of-use assets	46,370	46,620
Goodwill	185,439	182,956
Intangible assets, net	72,008	74,115
Other assets	2,927	3,188
Total assets	813,420	831,143
Current liabilities:
Accounts payable	55,106	74,371
Accrued liabilities	46,478	50,319
Income taxes payable	0	384
Current maturities of long-term debt	2,500	2,365
Current operating lease liabilities	7,370	7,224
Total current liabilities	111,454	134,663
Long-term debt	61,594	66,435
Noncurrent operating lease liabilities	40,084	40,361
Deferred income taxes	30,737	29,133
Other liabilities	14,522	14,997
Total liabilities	258,391	285,589
Commitments and contingencies
Stockholders’ equity:
Preferred stock, no par value, shares authorized 1,000,000; issued and outstanding - none	0	0
Common stock, $0.01 par value, shares authorized 125,000,000; issued 37,127,024 and 37,176,958, respectively; outstanding 33,103,593 and 33,011,119, respectively	371	372
Additional paid-in-capital	248,715	251,576
Retained earnings	412,922	409,318
Accumulated other comprehensive loss	(32,060)	(38,141)
Less: Treasury stock at cost, 4,023,431 and 4,165,839 shares, respectively	(74,919)	(77,571)
Total stockholders’ equity	555,029	545,554
Total liabilities and stockholders' equity	$ 813,420	$ 831,143

XML

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) $ in Thousands	Jan. 31, 2024	Oct. 31, 2023
Statement of Financial Position [Abstract]
Allowance for credit losses	$ 986	$ 843
Accumulated depreciation of property, plant and equipment	$ 375,560	$ 368,763
Preferred stock, no par value	$ 0	$ 0
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (in usd per share)	$ 0.01	$ 0.01
Common stock, shares authorized	125,000,000	125,000,000
Common stock, shares issued	37,127,024	37,176,958
Common stock, shares outstanding	33,103,593	33,011,119
Treasury stock, common, shares	4,023,431	4,165,839

XML

Condensed Consolidated Statements of Income (Loss) (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Jan. 31, 2024	Jan. 31, 2023
Income Statement [Abstract]
Net sales	$ 239,155	$ 261,916
Cost and expenses:
Cost of sales (excluding depreciation and amortization)	187,723	210,149
Selling, general and administrative	32,363	36,744
Depreciation and amortization	11,152	10,620
Operating income	7,917	4,403
Non-operating (expense) income:
Interest expense	(1,068)	(2,259)
Other, net	1,042	218
Income before income taxes	7,891	2,362
Income tax expense	(1,642)	(453)
Net income	$ 6,249	$ 1,909
Basic earnings per common share	$ 0.19	$ 0.06
Diluted earnings per common share	$ 0.19	$ 0.06
Weighted-average common shares outstanding:
Basic (in shares)	32,825	32,951
Diluted (in shares)	33,043	33,137
Cash dividends per share (in usd per share)	$ 0.08	$ 0.08

XML

Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Jan. 31, 2024	Jan. 31, 2023
Statement of Comprehensive Income [Abstract]
Net income	$ 6,249	$ 1,909
Other comprehensive income:
Foreign currency translation gain	6,081	11,372
Other comprehensive income	6,081	11,372
Comprehensive income	$ 12,330	$ 13,281

XML

Condensed Consolidated Statements of Cash Flow (Unaudited) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Oct. 31, 2023
Operating activities:
Net income	$ 6,249	$ 1,909
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization	11,152	10,620
Stock-based compensation	583	679
Deferred income tax	1,136	179
Other, net	1,790	1,509
Changes in assets and liabilities:
Decrease in accounts receivable	18,147	20,502
(Increase) decrease in inventory	(8,756)	645
Increase in other current assets	(1,680)	(1,431)
Decrease in accounts payable	(19,044)	(21,379)
Decrease in accrued liabilities	(7,181)	(12,686)
Increase in income taxes payable	264	536
Increase in deferred pension benefits	0	7
Increase in other long-term liabilities	852	1,461
Other, net	342	584
Cash provided by operating activities	3,854	3,135
Investing activities:
Business acquisition	0	(92,000)	$ (91,300)
Capital expenditures	(9,580)	(7,582)
Proceeds from disposition of capital assets	31	98
Cash used for investing activities	(9,549)	(99,484)
Financing activities:
Borrowings under credit facility	0	102,000
Repayments of credit facility borrowings	(5,000)	(15,000)
Repayments of other long-term debt	(679)	(579)
Common stock dividends paid	(2,645)	(2,661)
Issuance of common stock	400	99
Payroll tax paid to settle shares forfeited upon vesting of stock	(1,193)	(545)
Cash (used for) provided by financing activities	(9,117)	83,314
Effect of exchange rate changes on cash and cash equivalents	760	997
Decrease in cash and cash equivalents	(14,052)	(12,038)
Cash and cash equivalents at beginning of period	58,474	55,093	55,093
Cash and cash equivalents at end of period	$ 44,422	$ 43,055	$ 58,474

XML

Condensed Consolidated Statement of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Treasury Stock, Common
Balance at beginning of period at Oct. 31, 2022	$ 464,835	$ 372	$ 251,947	$ 337,456	$ (49,422)	$ (75,518)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	1,909			1,909
Foreign currency translation adjustment	11,372				11,372
Common dividends ($0.08 per share)	(2,661)			(2,661)
Stock-based compensation activity:
Expense related to stock-based compensation	679		679
Stock options exercised	99		6			93
Restricted stock awards granted			(1,752)			1,752
Performance restricted stock units vested			(605)			605
Other	(545)		(545)
Balance at end of period at Jan. 31, 2023	475,688	372	249,730	336,704	(38,050)	(73,068)
Balance at beginning of period at Oct. 31, 2023	545,554	372	251,576	409,318	(38,141)	(77,571)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	6,249			6,249
Foreign currency translation adjustment	6,081				6,081
Common dividends ($0.08 per share)	(2,645)			(2,645)
Stock-based compensation activity:
Expense related to stock-based compensation	583		583
Stock options exercised	400		22			378
Restricted stock awards granted			(1,357)			1,357
Performance restricted stock units vested			(917)			917
Other	(1,193)	(1)	(1,192)
Balance at end of period at Jan. 31, 2024	$ 555,029	$ 371	$ 248,715	$ 412,922	$ (32,060)	$ (74,919)

XML

Condensed Consolidated Statement of Stockholders' Equity (Unaudited) (Parenthetical) - $ / shares	3 Months Ended
	Jan. 31, 2024	Jan. 31, 2023
Statement of Stockholders' Equity [Abstract]
Cash dividends per share (in usd per share)	$ 0.08	$ 0.08

XML

Nature of Operations and Basis of Presentation

3 Months Ended

Jan. 31, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Nature of Operations and Basis of Presentation

Nature of Operations and Basis of Presentation

Quanex Building Products Corporation is a global, publicly traded manufacturing company primarily serving original equipment manufacturers (OEMs) in the fenestration, cabinetry, solar, refrigeration and outdoor products markets. These components can be categorized as window and door (fenestration) components and kitchen and bath cabinet components. Examples of fenestration components include: (1) energy-efficient flexible insulating glass spacers, (2) extruded vinyl profiles, (3) window and door screens, and (4) precision-formed metal and wood products. We also manufacture cabinet doors and other components for OEMs in the kitchen and bathroom cabinet industry. In addition, we provide certain other non-fenestration components and products, which include custom mixing, solar panel sealants, trim moldings, vinyl decking, vinyl fencing, customized compounds, water retention barriers, and conservatory roof components. We have organized our business into three reportable business segments. For additional discussion of our reportable business segments, see Note 11, “Segment Information.” We use low-cost, short lead-time production processes and engineering expertise to provide our customers with specialized products for their specific window, door, and cabinet applications. We believe these capabilities provide us with unique competitive advantages. We serve a primary customer base in North America and the United Kingdom (U.K.), and also serve customers in international markets through our operating plants in the U.K. and Germany, as well as through sales and marketing efforts in other countries.

Unless the context indicates otherwise, references to “Quanex”, the “Company”, “we”, “us” and “our” refer to the consolidated business operations of Quanex Building Products Corporation and its subsidiaries.

Basis of Presentation and Principles of Consolidation

The accompanying interim unaudited condensed consolidated financial statements include the accounts of Quanex Building Products Corporation. All intercompany accounts and transactions have been eliminated in consolidation. These financial statements have been prepared by us, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) have been condensed or omitted pursuant to such rules and regulations. The condensed consolidated balance sheet as of October 31, 2023 was derived from audited financial information but does not include all disclosures required by U.S. GAAP. The accompanying financial statements should be read in conjunction with the audited consolidated financial statements and the notes thereto, included in our Annual Report on Form 10-K for the fiscal year ended October 31, 2023. In our opinion, the accompanying financial statements contain all adjustments (which consist of normal recurring adjustments, except as disclosed herein) necessary to fairly present our financial position, results of operations and cash flows for the interim periods. The results of operations for the periods presented are not necessarily indicative of the results to be expected for the full year or for any future periods.

Use of Estimates

In preparing financial statements, we make informed judgments and estimates that affect the reported amounts of assets and liabilities as of the date of the financial statements and affect the reported amounts of revenues and expenses during the reporting period. We review our estimates on an on-going basis, including those related to impairment of long-lived assets and goodwill, contingencies and income taxes. Changes in facts and circumstances may result in revised estimates and actual results may differ from these estimates.

Revenue from Contracts with Customers

Revenue recognition

We recognize revenue that reflects the consideration we expect to receive for product sales upon transfer to customers. Revenue for product sales is recognized when control of the promised products is transferred to our customers, and we are entitled to consideration in exchange for such transfer. We account for a contract when a customer provides us with a firm purchase order that identifies the products to be provided, the payment terms for those products, and when collectability of the consideration due is probable.

Performance obligations

A performance obligation is a promise to provide the customer with a good or service. Our performance obligations include product sales, with each product included in a customer contract being recognized as a separate performance obligation.

For contracts with multiple performance obligations, the standalone selling price of each product is generally readily observable.

Revenue from product sales is recognized at a point in time when the product is transferred to the customer, in accordance with the shipping terms, which is generally upon shipment. We estimate a provision for sales returns and warranty allowances to account for product returns related to general returns and product nonconformance.

We generally expense incremental costs of obtaining a contract when incurred because the amortization period would be less than one year. Additionally, we do not disclose the value of unsatisfied performance obligations for contracts with an original expected length of one year or less.

Pricing and sales incentives

Pricing is established at or prior to the time of sale with our customers and we record sales at the agreed-upon net selling price, reflective of current and prospective discounts.

Shipping and handling costs

We account for shipping and handling services as fulfillment services; accordingly, freight revenue is combined with the product deliverable rather than being accounted for as a distinct performance obligation within the terms of the agreement. Shipping and handling costs incurred by us for the delivery of goods to customers are considered a cost to fulfill the contract and are included in cost of sales in the accompanying condensed consolidated statements of income.

Contract assets and liabilities

Deferred revenue, which is not significant, is recorded when we have remaining unsatisfied performance obligations for which we have received consideration.

Disaggregation of revenue

We produce a wide variety of products that are used in the fenestration industry, including window spacer systems; extruded vinyl products; metal fabricated products; and astragals, thresholds and screens. In addition, we produce certain non-fenestration products, including kitchen and bath cabinet doors and components, flooring and trim moldings, solar edge tape, plastic decking, fencing, water retention barriers, conservatory roof components, and other products.

The following table summarizes our product sales for the three months ended January 31, 2024 and 2023 into groupings by segment which we believe depicts how the nature, amount, timing and uncertainty of our revenues and cash flows are affected by economic factors. For further details regarding our results by segment, refer to Note 11, “Segment Information.”

	Three Months Ended
	January 31,
	2024		2023
	(In thousands)
North American Fenestration:
United States - fenestration	$	111,634	$	120,767
International - fenestration	6,144		5,127
United States - non-fenestration	25,791		23,066
International - non-fenestration	4,426		4,020
	$	147,995	$	152,980
European Fenestration:
International - fenestration	$	41,751	$	42,354
International - non-fenestration	7,686		12,598
	$	49,437	$	54,952
North American Cabinet Components:
United States - fenestration	$	3,675	$	3,908
United States - non-fenestration	39,179		50,049
International - non-fenestration	283		717
	$	43,137	$	54,674
Unallocated Corporate & Other
Eliminations	$	(1,414)	$	(690)
	$	(1,414)	$	(690)
Net sales	$	239,155	$	261,916

Allowance for Credit Losses

We have established an allowance for credit losses to estimate the risk of losses, which represents an estimate of expected losses over the remaining contractual life of our receivables. The allowance is determined using two methods. The amounts calculated from each of these methods are combined to determine the total amount reserved. First, a specific reserve is established for individual accounts where information indicates the customers may have an inability to meet financial obligations. Second, a reserve is determined for all customers based on a range of percentages applied to aging categories. These percentages are based on historical collection rates, write-off experience, and forecasts of future economic conditions. Actual write-offs are charged against the allowance when collection efforts have been unsuccessful.

Related Parties

Net sales include transactions with a customer which is a related party with one of our non-employee directors for the three months ended January 31, 2024 and 2023 of approximately $0.2 million, respectively. We performed a review of these transactions, of which no single transaction or series of related transactions exceeded $120,000 in amount, and determined that these transactions were enacted independently of each other. We are not aware of any other related party transactions with any of our current non-employee directors or officers outside of their normal business functions or expected contractual duties.

XML

Acquisition	3 Months Ended
	Jan. 31, 2024
Business Combinations [Abstract]
Asset Acquisition	AcquisitionOn November 1, 2022, we entered into an Asset Purchase Agreement (the “Purchase Agreement”) with LMI Custom Mixing, LLC (“LMI”) and the equity owners of LMI, Lauren International, Ltd. and Meteor-US-Beteiligungs GMBH. Under the Purchase Agreement, we acquired substantially all of the operating assets comprising LMI’s polymer mixing and rubber compound production business (collectively, the “Purchased Assets”) and also agreed to assume certain liabilities relating to the Purchased Assets (collectively, the “Acquisition”). As consideration for the Purchased Assets, we paid $91.3 million in cash utilizing funds borrowed under our Credit Facility. In connection with the Acquisition, we amended our existing finance lease with Lauren Real Estate Holding LLC for the purpose of adding an additional lease renewal option and increasing rental space by approximately 60,000 square feet of rental space which was added to the 313,595 square feet of rentable area located in Cambridge, Ohio.

XML

Inventories

3 Months Ended

Jan. 31, 2024

Inventory Disclosure [Abstract]

Inventories

Inventories

Inventories consisted of the following at January 31, 2024 and October 31, 2023 (in thousands):

	January 31, 2024		October 31, 2023
Raw materials	$	60,659	$	53,585
Finished goods and work in process	44,322		42,195
Supplies and other	2,497		2,179
Total	$	107,478	$	97,959

Fixed costs related to excess manufacturing capacity, if any, have been expensed in the period they were incurred and, therefore, are not capitalized into inventory.

XML

Goodwill and Intangible Assets

3 Months Ended

Jan. 31, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Intangible Assets

Goodwill and Intangible Assets

Goodwill

The change in the carrying amount of goodwill for the three months ended January 31, 2024 was as follows (in thousands):

	Three Months Ended
	January 31, 2024
Beginning balance as of November 1, 2023	$	182,956
Foreign currency translation adjustment	2,483
Balance as of the end of the period	$	185,439

At our last annual test date, August 31, 2023, we evaluated the recoverability of goodwill at each of our five reporting units with goodwill balances and determined that our goodwill was not impaired. We evaluated for indicators of impairment for all reporting units during the three months ended January 31, 2024 and determined that there were no triggering events. For additional discussion of change in reporting units and a summary of the change in the carrying amount of goodwill by segment, see Note 11, “Segment Information.”

Identifiable Intangible Assets

Amortizable intangible assets consisted of the following as of January 31, 2024 and October 31, 2023 (in thousands):

	January 31, 2024				October 31, 2023
	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization
Customer relationships	$	159,184	$	102,324	$	157,629	$	99,230
Trademarks and trade names	56,003		43,824		55,519		42,879
Patents and other technology	25,154		22,185		25,127		22,051
Total	$	240,341	$	168,333	$	238,275	$	164,160

We had aggregate amortization expense related to intangible assets for the three months ended January 31, 2024 of $3.2 million and $3.1 million for the comparable prior year period.

Estimated remaining amortization expense, assuming current intangible balances and no new acquisitions, for future fiscal years as of January 31, 2024 (in thousands):

	Estimated Amortization Expense
2024 (remaining nine months)	$	8,540
2025	10,355
2026	10,113
2027	10,114
2028	4,880
Thereafter	28,006
Total	$	72,008

XML

Debt and Finance Lease Obligations

3 Months Ended

Jan. 31, 2024

Debt Disclosure [Abstract]

Debt and Finance Lease Obligations

Debt and Finance Lease Obligations

Long-term debt consisted of the following at January 31, 2024 and October 31, 2023 (in thousands):

	January 31, 2024		October 31, 2023
Revolving Credit Facility	$	10,000	$	15,000
Finance lease obligations and other	55,211		55,000
Unamortized deferred financing fees	(1,117)		(1,200)
Total debt	$	64,094	$	68,800
Less: Current maturities of long-term debt	2,500		2,365
Long-term debt	$	61,594	$	66,435

Revolving Credit Facility

On July 6, 2022, we entered into our Second Amended and Restated Credit Agreement (the “Credit Facility”) with Wells Fargo Securities, LLC, as Agent, Swingline Lender and Issuing Lender, and BofA Securities, Inc. serving as Syndication Agent. We capitalized $1.2 million of deferred financing fees related to the Credit Facility. This $325.0 million revolving credit facility has a five-year term, maturing on July 6, 2027, and replaces our previous credit facility. Our previous credit facility is more fully described in our Annual Report on Form 10-K for the fiscal year ended October 31, 2023.

Interest payments for the Credit Facility are calculated, at our election and depending upon the Consolidated Net Leverage Ratio, at a Base Rate (as defined within the Credit Facility) plus an applicable margin or at the same rate as Risk-Free Rate (“RFR”) Loans for domestic borrowings or Eurocurrency Rate Loans plus an applicable margin. In addition, we are subject to commitment fees for the unused portion of the Credit Facility.

The applicable margin and commitment fees are outlined in the following table:

Pricing Level	Consolidated Net Leverage Ratio	Commitment Fee	Eurocurrency Rate Loans and RFR Loans	Base Rate Loans
I	Less than or equal to 1.50 to 1.00	0.150%	1.25%	0.25%
II	Greater than 1.50 to 1.00, but less than or equal to 2.25 to 1.00	0.175%	1.50%	0.50%
III	Greater than 2.25 to 1.00, but less than or equal to 3.00 to 1.00	0.200%	1.75%	0.75%
IV	Greater than 3.00 to 1.00	0.250%	2.00%	1.00%

In the event of default, outstanding borrowings would accrue interest at the Default Rate, as defined, whereby the obligations will bear interest at a per annum rate equal to 2% above the total per annum rate otherwise applicable.

The Credit Facility provides for incremental revolving credit commitments for a minimum principal amount of $10.0 million, up to an aggregate amount of $150.0 million or 100% of Consolidated EBITDA, subject to the lender's discretion to elect or decline the incremental increase. We can also borrow up to the lesser of $15.0 million or the revolving credit commitment, as defined, under a Swingline feature of the Credit Facility.

The Credit Facility contains a: (1) Consolidated Interest Coverage Ratio requirement whereby we must not permit the Consolidated Interest Coverage Ratio, as defined, to be less than 3.00 to 1.00, and (2) Consolidated Net Leverage Ratio requirement, whereby we must not permit the Consolidated Net Leverage Ratio, as defined, to be greater than 3.25 to 1.00.

In addition to maintaining these financial covenants, the Credit Facility also limits our ability to enter into certain business transactions, such as to incur indebtedness or liens, to acquire businesses or dispose of material assets, make restricted payments, pay dividends (limited to $25.0 million per year) and other transactions as further defined in the Credit Facility. Some of these limitations, however, do not take effect so long as Consolidated Net Leverage Ratio is less than or equal to 2.75 to 1.00 and available liquidity exceeds $25.0 million. Substantially all of our domestic assets, with the exception of real property, are used as collateral for the Credit Agreement.

As of January 31, 2024, we had $10.0 million of borrowings outstanding under the Credit Facility (reduced by unamortized debt issuance costs of $1.1 million), $5.1 million of outstanding letters of credit and $55.2 million outstanding primarily under finance leases and other debt. We had $309.9 million available for use under the Credit Facility at January 31, 2024. Outstanding borrowings under the Credit Facility accrue interest at 6.68% per annum. Our weighted-average borrowing rate for borrowings outstanding during the three months ended January 31, 2024 and 2023 was 6.69% and 5.43%, respectively. We were in compliance with our debt covenants as of January 31, 2024.

XML

Retirement Plans

3 Months Ended

Jan. 31, 2024

Retirement Benefits [Abstract]

Retirement Plans

Retirement Plans

Pension Plan

Our non-contributory, single employer defined benefit pension plan covered certain of our employees in the U.S. During the year ended October 31. 2023, we terminated our defined contribution plan and settled the obligation during the three months ended October 31, 2023. The net periodic pension (benefit) cost for this plan for the three months ended January 31, 2024 and 2023 was as follows (in thousands):

	Three Months Ended
	January 31,
	2024		2023
Service cost	$	—	$	96
Interest cost	—		390
Expected return on plan assets	—		(366)
Amortization of net loss	—		10
Settlement reimbursement	(765)		—
Net periodic pension (benefit) cost	$	(765)	$	130

Other Plans

We also have a supplemental benefit plan covering certain executive officers and key employees and a non-qualified deferred compensation plan covering members of the Board of Directors and certain key employees. As of January 31, 2024 and October 31, 2023, our liability under the supplemental benefit plan was approximately $2.0 million. During the year ended October 31, 2023, the supplemental benefit plan was terminated. Benefits associated with this plan will be distributed in June 2024 in accordance with Internal Revenue Service regulations. As of January 31, 2024 and October 31, 2023, the liability associated with the deferred compensation plan was approximately $4.5 million and $3.9 million, respectively. We record the current portion of liabilities associated with these plans under the caption “Accrued liabilities,” and the long-term portion under the caption “Other liabilities” in the accompanying condensed consolidated balance sheets.

XML

Income Taxes

3 Months Ended

Jan. 31, 2024

Income Tax Disclosure [Abstract]

Income Taxes

Income Taxes

To determine our income tax expense or benefit for interim periods, consistent with accounting standards, we apply the estimated annual effective income tax rate to year-to-date results, plus any applicable discrete items, which are recorded in the period in which they occur. Discrete items include, among others, such events as changes in estimates due to the finalization of tax returns, tax audit settlements, expiration of statutes of limitations, tax benefits on equity compensation, and increase or decrease in valuation allowances on deferred tax assets. Our annual effective tax rates from continuing operations for the three months ended January 31, 2024 and 2023 were 20.8% and 19.2%, respectively. The difference between our effective income tax rate and the U.S. federal statutory rate of 21% principally results from discrete tax items, U.S. state tax, non-U.S. tax rate differential and other permanent differences. The primary discrete items affecting the 2024 effective rate were the benefit of $0.4 million related to the vesting or exercise of equity-based compensation awards, and a charge of $0.6 million related to the true up of the deferred tax rate. The primary discrete item affecting the 2023 effective rate was a benefit of $0.2 million related to foreign entities true up.

As of January 31, 2024, our liability for uncertain tax positions (UTP) of $0.3 million relates to certain U.S. federal and state tax items regarding the interpretation of tax laws and regulations, including a minimal amount of interest and penalties. We include all interest and penalties related to uncertain tax benefits within our income tax provision account. To the extent interest and penalties are not assessed with respect to uncertain tax positions or the uncertainty of deductions in the future, amounts accrued will be reduced and reflected as a reduction of the overall income tax provision.

We evaluate the likelihood of realization of our deferred tax assets by considering both positive and negative evidence. We maintain a valuation allowance for certain state net operating losses which totaled $0.6 million as of January 31, 2024 and October 31, 2023, respectively.

XML

Contingencies

3 Months Ended

Jan. 31, 2024

Commitments and Contingencies Disclosure [Abstract]

Contingencies

Contingencies

Remediation and Environmental Compliance Costs

Under applicable state and federal laws, we may be responsible for, among other things, all or part of the costs required to remove or remediate wastes or hazardous substances at locations we, or our predecessors, have owned or operated. From time to time, we also have been alleged to be liable for all or part of the costs incurred to clean up third-party sites where there might have been an alleged improper disposal of hazardous substances. Currently, we are not involved in any such matters.

From time to time, we incur routine expenses and capital expenditures associated with compliance with existing environmental regulations, including control of air emissions and water discharges, and plant decommissioning costs. We have not incurred any material expenses or capital expenditures related to environmental matters during the past three fiscal years, and do not expect to incur a material amount of such costs in fiscal 2024. While we will continue to have future expenditures related to environmental matters, any such amounts are impossible to reasonably estimate at this time. Based upon our experience to date, we do not believe that our compliance with environmental requirements will have a material adverse effect on our operations, financial condition or cash flows.

Litigation

From time to time, we, along with our subsidiaries, are involved in various litigation matters arising in the ordinary course of our business, including those arising from or related to contractual matters, commercial disputes, intellectual property, personal injury, environmental matters, product performance or warranties, product liability, insurance coverage and personnel and employment disputes. We regularly review with legal counsel the status of all ongoing proceedings, and we maintain insurance against these risks to the extent deemed prudent by our management and to the extent such insurance is available. However, there is no assurance that we will prevail in these matters or that our insurers will accept full coverage of these matters, and we could, in the future, incur judgments, enter into settlements of claims, or revise our expectations regarding the outcome or insurability of matters we face, which could materially impact our results of operations.

We have been and are currently party to multiple claims, some of which are in litigation, relating to alleged defects in a commercial sealant product that was manufactured and sold during the 2000’s. While we believe that our product was not defective and that we would prevail in these commercial sealant product claims if taken to trial, the timing, ultimate resolution and potential impact of these claims is not currently determinable. Nevertheless, after taking into account all currently available information, including our defenses, the advice of our counsel, and the extent and currently-expected availability of our existing insurance coverage, we believe that the eventual outcome of these commercial sealant claims will not have a material adverse effect on our overall financial condition, results of operations or cash flows, and we have not recorded any accrual with regard to these claims.

XML

Fair Value Measurement of Assets and Liabilities

3 Months Ended

Jan. 31, 2024

Fair Value Disclosures [Abstract]

Fair Value Measurement of Assets and Liabilities

Fair Value Measurement of Assets and Liabilities

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value hierarchy distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity's own assumptions about market data developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to Level 1 and the lowest priority to Level 3. The three levels of the fair value hierarchy are described below:

•Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.

•Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability either directly or indirectly including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates) and inputs that are derived principally from or corroborated by observable market data by correlation or other means.

•Level 3 - Inputs that are both significant to the fair value measurement and unobservable.

Carrying amounts reported on the balance sheet for cash, cash equivalents, accounts receivable and accounts payable approximate fair value due to the short-term maturity of these instruments. Our outstanding debt is variable rate debt that re-prices frequently, thereby limiting our exposure to significant change in interest rate risk. As a result, the fair value of our debt instrument approximates carrying value at January 31, 2024, and October 31, 2023 (Level 2 measurement).

Our performance share awards are marked-to-market on a quarterly basis during a three-year vesting period based on market data (Level 2 measurement). For further information, refer to Note 10, “Stock-Based Compensation - Performance Share Awards.”

We used recognized valuation techniques to determine the preliminary fair value of the assets and liabilities, including the excess earnings method for customer relationships and relief from royalty method for trade names and other technology with a discount rate that reflects the risk of the expected future cash flows (Level 3 measurement). For further information, refer to Note 2, “Acquisition.”

XML

Stock-Based Compensation

3 Months Ended

Jan. 31, 2024

Share-Based Payment Arrangement [Abstract]

Stock-Based Compensation

Stock-Based Compensation

We have established and maintain an Omnibus Incentive Plan (2020 Plan) that provides for the granting of restricted stock awards, stock options, restricted stock units, performance share awards, performance restricted stock units, and other stock-based and cash-based awards. The 2020 Plan is administered by the Compensation and Management Development Committee of the Board of Directors.

The aggregate number of shares of common stock authorized for grant under the 2020 Plan is 3,139,895 as approved by shareholders. Any officer, key employee and/or non-employee director is eligible for awards under the 2020 Plan. We grant restricted stock units to non-employee directors on the first business day of each fiscal year. As approved by the Compensation & Management Development Committee of our Board of Directors annually, we grant a mix of restricted stock awards, performance shares and performance restricted stock units to officers, management and key employees. We also historically granted stock options to certain officers, directors and key employees. Occasionally, we may make additional grants to key employees at other times during the year.

Restricted Stock Awards

Restricted stock awards are granted to key employees and officers annually, and typically cliff vest over a three-year period with service and continued employment as the only vesting criteria. The recipient of the restricted stock award is entitled to all of the rights of a shareholder, except that the award is nontransferable during the vesting period and quarterly dividends are not paid until the award vests. The fair value of the restricted stock award is established on the grant date and then expensed over the vesting period resulting in an increase in additional paid-in-capital. Shares are generally issued from treasury stock at the time of grant.

A summary of non-vested restricted stock awards activity during the three months ended January 31, 2024 is presented below:

	Restricted Stock Awards	Weighted-Average Grant Date Fair Value per Share
Non-vested at October 31, 2023	242,300	$	22.36
Granted	72,900	32.15
Forfeited	(11,800)	22.30
Vested	(66,600)	20.68
Non-vested at January 31, 2024	236,800	$	25.85

The total weighted-average grant-date fair value of restricted stock awards that vested during each of the three months ended January 31, 2024 and 2023 was $1.4 million and $0.9 million, respectively. As of January 31, 2024, total unrecognized compensation cost related to unamortized restricted stock awards was $4.0 million. We expect to recognize this expense over the remaining weighted-average vesting period of 2.3 years.

Stock Options

Historically, stock options have been awarded to key employees, officers and non-employee directors. In December 2017, the Compensation & Management Development Committee of the Board of Directors approved a change to the long-term incentive award program eliminating the grant of stock options and replacing this award with a grant of performance restricted stock units and performance shares as further described below. As a result, the final stock options were granted during the fiscal year ended October 31, 2017. Stock options typically vested ratably over a three-year period with service and continued employment as the vesting conditions. Our stock options may be exercised up to a maximum of ten years from the date of grant. The fair value of the stock options was determined on the grant date and expensed over the vesting period resulting in an

increase in additional paid-in-capital. For employees who were nearing retirement-eligibility, we recognize stock option expense ratably over the shorter of the vesting period or the period from the grant-date to the retirement-eligibility date.

We use a Black-Scholes pricing model to estimate the fair value of stock options. A description of the methodology for the valuation assumptions was disclosed in our Annual Report on Form 10-K for the fiscal year ended October 31, 2023.

The following table summarizes our stock option activity for the three months ended January 31, 2024:

	Stock Options	Weighted-Average Exercise Price		Weighted-Average Remaining Contractual Term (in years)	Aggregate Intrinsic Value (000s)
Outstanding at October 31, 2023	107,530	$	19.48
Exercised	(20,280)	19.70
Outstanding at January 31, 2024	87,250	$	19.43	2.2	$	1,028
Vested at January 31, 2024	87,250	$	19.43	2.2	$	1,028
Exercisable at January 31, 2024	87,250	$	19.43	2.2	$	1,028

Intrinsic value is the amount by which the market price of the common stock on the date of exercise exceeds the exercise price of the stock option. The total intrinsic value of stock options exercised during the three months ended January 31, 2024 and 2023 was $0.2 million and less than $0.1 million, respectively.

Restricted Stock Units

Restricted stock units may be awarded to key employees and officers from time to time, and annually to non-employee directors. The non-employee director restricted stock units vest immediately but are payable only upon the director's cessation of service unless an election is made by the non-employee director to settle and pay the award on an earlier specified date. Restricted stock units awarded to employees and officers typically cliff vest after a three-year period with service and continued employment as the vesting conditions. Restricted stock units are not considered outstanding shares and do not have voting rights, although the holder does receive a cash payment equivalent to the dividend paid, on a one-for-one basis, on our outstanding common shares. Once the criteria is met, each restricted stock unit is payable to the holder in cash based on the market value of one share of our common stock. Accordingly, we record a liability for the restricted stock units on our balance sheet and recognize any changes in the market value during each reporting period as compensation expense.

During the three months ended January 31, 2024 and 2023, non-employee directors received 26,215 and 38,704 restricted stock units, respectively, at a weighted-average grant date fair value of $26.70 per share and $20.67 per share, respectively, which vested immediately. During the three months ended January 31, 2023, 21,774 restricted stock units, which were awarded to key employees, vested. During the three months ended January 31, 2024, we paid $0.1 million and $0.4 million for the comparable prior year to settle vested restricted stock units.

Performance Share Awards

We have awarded annual grants of performance shares to key employees and officers. Performance share awards vest with return on net assets (RONA) as the vesting condition and pay out 100% in cash, and are accounted for as liability.

The expected cash settlement of the performance share award is recorded as a liability and is being marked to market over the three-year term of the award and can fluctuate depending on the number of shares ultimately expected to vest. Depending on the achievement of the performance conditions, 0% to 200% of the awarded performance shares may ultimately vest.

The following table summarizes our performance share grants and the grant date fair value for the RONA performance metrics:

Grant Date	Shares Awarded	Grant Date Fair Value		Shares Forfeited
December 9, 2021	80,900	$	22.54	4,600
December 7, 2022	89,300	$	23.49	4,600
December 7, 2023	72,200	$	32.15	—

In December 2023, 122,400 shares vested pursuant to the December 2020 grant, which were settled with a cash payment of $3.4 million.

Performance share awards are payable in cash based upon the number of performance shares ultimately earned, and are therefore not considered outstanding shares.

Performance Restricted Stock Units

We award performance restricted stock units to key employees and officers. These awards cliff vest upon a three-year service period with the absolute total shareholder return of our common stock over this three-year term as the vesting criteria. The number of shares earned is variable depending on the metric achieved, and the settlement method is 100% in our common stock, with accrued dividends paid in cash at the time of vesting, assuming the shares had been outstanding throughout the performance period.

To value the performance restricted stock units, we used a Monte Carlo simulation model to arrive at a grant-date fair value. This amount will be adjusted for forfeitures and expensed over the three-year term of the award with a credit to additional paid-in-capital. Depending on the achievement of the performance conditions, a minimum of 0% and a maximum of 150% of the awarded performance restricted stock units may vest. Specifically, the awards vest on a continuum with the following Absolute Total Shareholder Return (A-TSR) milestones:

Vesting Level	Vesting Criteria	Percentage of Award Vested
Level 1	A-TSR greater than or equal to 50%	150%
Level 2	A-TSR less than 50% and greater than or equal to 20%	100%
Level 3	A-TSR less than 20% and greater than or equal to -20%	50%
Level 4	A-TSR less than -20%	—%

The following table summarizes our performance restricted stock unit grants and the grant date fair value for the A-TSR performance metric:

Grant Date	Shares Awarded	Grant Date Fair Value		Shares Forfeited
December 9, 2021	50,900	$	21.06	3,400
December 7, 2022	51,500	$	23.22	3,100
December 7, 2023	40,700	$	30.35	—

During the three months ended January 31, 2024, 49,228 performance restricted stock units vested.

The performance restricted stock units are not considered outstanding shares, do not have voting rights, and are excluded from diluted weighted-average shares used to calculate earnings per share until the performance criteria is probable to result in the issuance of contingent shares. As of January 31, 2024, we have deemed 58,957 shares related to the December 2021 grant of performance restricted stock units as probable to vest.

The following table summarizes amounts expensed as selling, general and administrative expense related to restricted stock awards, stock options, restricted stock units, performance share awards and performance restricted stock units for the three months ended January 31, 2024 and 2023 (in thousands):

	Three Months Ended
	January 31,
	2024		2023
Restricted stock awards	$	317	$	438
Restricted stock units	1,424		1,491
Performance share awards	569		2,639
Performance restricted stock units	266		241
Total compensation expense	$	2,576	$	4,809

Treasury Shares

We record treasury stock purchases under the cost method whereby the entire cost of the acquired stock is recorded as treasury stock. Shares are generally issued from treasury stock at the time of grant of restricted stock awards, upon the exercise of stock options, and upon the vesting of performance shares and performance restricted stock units. On the subsequent issuance of treasury shares, we record proceeds in excess of cost as an increase in additional paid in capital. A deficiency of such proceeds relative to costs would be applied to reduce paid-in-capital associated with prior issuances to the extent available, with the remainder recorded as a charge to retained earnings. There were no charges to retained earnings during the three months ended January 31, 2024.

The following table summarizes the treasury stock activity during the three months ended January 31, 2024:

	Three Months Ended
	January 31, 2024
Beginning Balance as of November 1, 2023	4,165,839
Restricted stock awards granted	(72,900)
Performance restricted stock units vested	(49,228)
Stock options exercised	(20,280)
Balance at January 31, 2024	4,023,431

XML

Segment Information

3 Months Ended

Jan. 31, 2024

Segment Reporting [Abstract]

Segment Information

Segment Information

We present three reportable business segments (1) NA Fenestration, comprising four operating segments primarily focused on the fenestration market in North America including vinyl profiles, insulating glass spacers, screens, custom compound mixing, and other fenestration components; (2) EU Fenestration, comprising our U.K.-based vinyl extrusion business, manufacturing vinyl profiles & conservatories, and the European insulating glass business manufacturing insulating glass spacers; and (3) NA Cabinet Components, comprising our cabinet door and components operations. Additionally, we maintain an Unallocated Corporate & Other which includes transaction expenses, stock-based compensation, long-term incentive awards based on the performance of our common stock and other factors, certain severance, legal, and other costs not deemed to be allocable to all segments, depreciation of corporate assets, interest expense, other, net, income taxes and inter-segment eliminations, and executive incentive compensation and medical expense fluctuations relative to planned costs as determined during the annual planning process. Other general and administrative costs associated with the corporate office are allocated to the reportable segments, based upon a relative measure of profitability in order to more accurately reflect each reportable business segment's administrative costs. We allocate corporate expenses to businesses acquired mid-year from the date of acquisition. The accounting policies of our operating segments are the same as those used to prepare the accompanying condensed consolidated financial statements. Corporate general and administrative expense allocated during the three month period ended January 31, 2024 was $7.3 million and $4.3 million for the comparable prior year period.

ASC Topic 280-10-50, “Segment Reporting” (ASC 280) permits aggregation of operating segments based on factors including, but not limited to: (1) similar nature of products serving the building products industry, primarily the fenestration business; (2) similar production processes, although there are some differences in the amount of automation amongst operating plants; (3) similar types or classes of customers, namely the primary OEMs; (4) similar distribution methods for product

delivery, although the extent of the use of third-party distributors will vary amongst the businesses; (5) similar regulatory environment; and (6) converging long-term economic similarities.

Segment information for the three months ended January 31, 2024 and 2023, and total assets as of January 31, 2024 and October 31, 2023 are summarized in the following table (in thousands):

	NA Fenestration		EU Fenestration		NA Cabinet Components		Unallocated Corp. & Other		Total
Three Months Ended January 31, 2024
Net sales	$	147,995	$	49,437	$	43,137	$	(1,414)	$	239,155
Depreciation and amortization	5,475		2,558		3,065		54		11,152
Operating income (loss)	8,242		7,431		(3,797)		(3,959)		7,917
Capital expenditures	5,721		1,801		1,836		222		9,580
Three Months Ended January 31, 2023
Net sales	$	152,980	$	54,952	$	54,674	$	(690)	$	261,916
Depreciation and amortization	5,245		2,348		2,934		93		10,620
Operating income (loss)	9,723		7,396		(1,189)		(11,527)		4,403
Capital expenditures	3,613		1,956		1,860		153		7,582
As of January 31, 2024
Total assets	$	372,328	$	242,615	$	156,353	$	42,124	$	813,420
As of October 31, 2023
Total assets	$	379,286	$	239,333	$	158,824	$	53,700	$	831,143

The following table summarizes the change in the carrying amount of goodwill by reportable business segment for the three months ended January 31, 2024 (in thousands):

	NA Fenestration		EU Fenestration		NA Cabinet Comp.		Unallocated Corp. & Other		Total
Balance as of October 31, 2023	$	80,105	$	63,704	$	39,147	$	—	$	182,956
Foreign currency translation adjustment	—		2,483		—		—		2,483
Balance as of January 31, 2024	$	80,105	$	66,187	$	39,147	$	—	$	185,439

For further details of Goodwill, see Note 4, “Goodwill & Intangible Assets,” located herewith.

We did not allocate non-operating loss or income tax benefit to the reportable segments. The following table reconciles operating income as reported above to net income for the three months ended January 31, 2024 and 2023 (in thousands):

	Three Months Ended
	January 31,
	2024		2023
Operating income	$	7,917	$	4,403
Interest expense	(1,068)		(2,259)
Other, net	1,042		218
Income tax expense	(1,642)		(453)
Net income	$	6,249	$	1,909

XML

Earnings Per Share

3 Months Ended

Jan. 31, 2024

Earnings Per Share [Abstract]

Earnings Per Share

Earnings Per Share

We compute basic earnings per share by dividing net income by the weighted-average number of common shares outstanding during the period. Diluted earnings per common and potential common shares include the weighted-average of additional shares associated with the incremental effect of dilutive employee stock options, non-vested restricted stock as

determined using the treasury stock method prescribed by U.S. GAAP and contingent shares associated with performance share awards, if dilutive.

Basic and diluted earnings per share for the three months ended January 31, 2024 and 2023 were calculated as follows (in thousands, except per share data):

	Net Income		Weighted-Average Shares	Per Share
Three Months Ended January 31, 2024
Basic earnings per common share	$	6,249	32,825	$	0.19
Effect of dilutive securities:
Stock options	—		35	—
Restricted stock awards	—		124	—
Performance restricted stock units	—		59	—
Diluted earnings per common share	$	6,249	33,043	$	0.19
Three Months Ended January 31, 2023
Basic earnings per common share	$	1,909	32,951	$	0.06
Effect of dilutive securities:
Stock options	—		32	—
Restricted stock awards	—		111	—
Performance restricted stock units	—		43	—
Diluted earnings per common share	$	1,909	33,137	$	0.06

We do not include equity instruments in our calculation of diluted earnings per share if those instruments would be anti-dilutive. Such dilution is dependent on the excess of the market price of our stock over the exercise price and other components of the treasury stock method. There were no anti-dilutive instruments for the three months ended January 31, 2024 and 2023.

XML

New Accounting Guidance

3 Months Ended

Jan. 31, 2024

Accounting Changes and Error Corrections [Abstract]

New Accounting Guidance

New Accounting Guidance

From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (“FASB”) or other standards setting bodies that we adopt as of the specified effective date. We did not adopt any new accounting pronouncements during the three months ended January 31, 2024.

Accounting Standards Not Yet Adopted

In November 2023, the FASB issued “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures,” which is intended to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024 with early adoption is permitted. The guidance is to be applied retrospectively to all prior periods presented in the financial statements. We are currently evaluating the potential impact of adopting this new guidance on our consolidated financial statements and related disclosures.

In December 2023, the FASB issued “Income Taxes (Topic 740): Improvements to Income Tax Disclosures,” which includes updates to the income tax disclosures related to the rate reconciliation and disaggregation of income taxes paid by jurisdiction. The amendments are effective for fiscal years beginning after December 15, 2024 with early adoption permitted. The amendments should be applied prospectively, however retrospective application is permitted. We are currently evaluating the potential impact of adopting this new guidance on our consolidated financial statements and related disclosures.

XML

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended
	Jan. 31, 2024	Jan. 31, 2023
Pay vs Performance Disclosure
Net income	$ 6,249	$ 1,909

XML

Insider Trading Arrangements

3 Months Ended

Jan. 31, 2024

Trading Arrangements, by Individual

Material Terms of Trading Arrangement

During the three months ended January 31, 2024, none of our directors or executive officers adopted or terminated any contract, instruction or written plan for the purchase or sale of our securities to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any “non-Rule 10b5-1 trading arrangement.”

Rule 10b5-1 Arrangement Adopted

false

Non-Rule 10b5-1 Arrangement Adopted

false

Rule 10b5-1 Arrangement Terminated

false

Non-Rule 10b5-1 Arrangement Terminated

false

XML

Nature of Operations and Basis of Presentation (Tables)

3 Months Ended

Jan. 31, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Disaggregation of Revenue

	Three Months Ended
	January 31,
	2024		2023
	(In thousands)
North American Fenestration:
United States - fenestration	$	111,634	$	120,767
International - fenestration	6,144		5,127
United States - non-fenestration	25,791		23,066
International - non-fenestration	4,426		4,020
	$	147,995	$	152,980
European Fenestration:
International - fenestration	$	41,751	$	42,354
International - non-fenestration	7,686		12,598
	$	49,437	$	54,952
North American Cabinet Components:
United States - fenestration	$	3,675	$	3,908
United States - non-fenestration	39,179		50,049
International - non-fenestration	283		717
	$	43,137	$	54,674
Unallocated Corporate & Other
Eliminations	$	(1,414)	$	(690)
	$	(1,414)	$	(690)
Net sales	$	239,155	$	261,916

XML

Inventories (Tables)

3 Months Ended

Jan. 31, 2024

Inventory Disclosure [Abstract]

Inventories

Inventories consisted of the following at January 31, 2024 and October 31, 2023 (in thousands):

	January 31, 2024		October 31, 2023
Raw materials	$	60,659	$	53,585
Finished goods and work in process	44,322		42,195
Supplies and other	2,497		2,179
Total	$	107,478	$	97,959

XML

Goodwill and Intangible Assets (Tables)

3 Months Ended

Jan. 31, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

Changes in the Carrying Amount of Goodwill

The change in the carrying amount of goodwill for the three months ended January 31, 2024 was as follows (in thousands):

	Three Months Ended
	January 31, 2024
Beginning balance as of November 1, 2023	$	182,956
Foreign currency translation adjustment	2,483
Balance as of the end of the period	$	185,439

The following table summarizes the change in the carrying amount of goodwill by reportable business segment for the three months ended January 31, 2024 (in thousands):

	NA Fenestration		EU Fenestration		NA Cabinet Comp.		Unallocated Corp. & Other		Total
Balance as of October 31, 2023	$	80,105	$	63,704	$	39,147	$	—	$	182,956
Foreign currency translation adjustment	—		2,483		—		—		2,483
Balance as of January 31, 2024	$	80,105	$	66,187	$	39,147	$	—	$	185,439

Schedule of Acquired Finite-Lived Intangible Assets by Major Class

Identifiable Intangible Assets

Amortizable intangible assets consisted of the following as of January 31, 2024 and October 31, 2023 (in thousands):

	January 31, 2024				October 31, 2023
	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization
Customer relationships	$	159,184	$	102,324	$	157,629	$	99,230
Trademarks and trade names	56,003		43,824		55,519		42,879
Patents and other technology	25,154		22,185		25,127		22,051
Total	$	240,341	$	168,333	$	238,275	$	164,160

Estimated Amortization Expense Related to Intangible Assets

	Estimated Amortization Expense
2024 (remaining nine months)	$	8,540
2025	10,355
2026	10,113
2027	10,114
2028	4,880
Thereafter	28,006
Total	$	72,008

XML

Debt and Finance Lease Obligations (Tables)

3 Months Ended

Jan. 31, 2024

Debt Disclosure [Abstract]

Debt and Finance Lease Obligations

Long-term debt consisted of the following at January 31, 2024 and October 31, 2023 (in thousands):

	January 31, 2024		October 31, 2023
Revolving Credit Facility	$	10,000	$	15,000
Finance lease obligations and other	55,211		55,000
Unamortized deferred financing fees	(1,117)		(1,200)
Total debt	$	64,094	$	68,800
Less: Current maturities of long-term debt	2,500		2,365
Long-term debt	$	61,594	$	66,435

Schedule of Applicable Margin and Commitment Fees

The applicable margin and commitment fees are outlined in the following table:

Pricing Level	Consolidated Net Leverage Ratio	Commitment Fee	Eurocurrency Rate Loans and RFR Loans	Base Rate Loans
I	Less than or equal to 1.50 to 1.00	0.150%	1.25%	0.25%
II	Greater than 1.50 to 1.00, but less than or equal to 2.25 to 1.00	0.175%	1.50%	0.50%
III	Greater than 2.25 to 1.00, but less than or equal to 3.00 to 1.00	0.200%	1.75%	0.75%
IV	Greater than 3.00 to 1.00	0.250%	2.00%	1.00%

XML

Retirement Plans (Tables)

3 Months Ended

Jan. 31, 2024

Retirement Benefits [Abstract]

Net Periodic Pension Cost

The net periodic pension (benefit) cost for this plan for the three months ended January 31, 2024 and 2023 was as follows (in thousands):

	Three Months Ended
	January 31,
	2024		2023
Service cost	$	—	$	96
Interest cost	—		390
Expected return on plan assets	—		(366)
Amortization of net loss	—		10
Settlement reimbursement	(765)		—
Net periodic pension (benefit) cost	$	(765)	$	130

XML

Stock-Based Compensation (Tables)

3 Months Ended

Jan. 31, 2024

Share-Based Payment Arrangement [Abstract]

Schedule of Nonvested Restricted Share Activity

A summary of non-vested restricted stock awards activity during the three months ended January 31, 2024 is presented below:

	Restricted Stock Awards	Weighted-Average Grant Date Fair Value per Share
Non-vested at October 31, 2023	242,300	$	22.36
Granted	72,900	32.15
Forfeited	(11,800)	22.30
Vested	(66,600)	20.68
Non-vested at January 31, 2024	236,800	$	25.85

Schedule of Stock Option Activity

The following table summarizes our stock option activity for the three months ended January 31, 2024:

	Stock Options	Weighted-Average Exercise Price		Weighted-Average Remaining Contractual Term (in years)	Aggregate Intrinsic Value (000s)
Outstanding at October 31, 2023	107,530	$	19.48
Exercised	(20,280)	19.70
Outstanding at January 31, 2024	87,250	$	19.43	2.2	$	1,028
Vested at January 31, 2024	87,250	$	19.43	2.2	$	1,028
Exercisable at January 31, 2024	87,250	$	19.43	2.2	$	1,028

Schedule of Performance Share Awards

The following table summarizes our performance share grants and the grant date fair value for the RONA performance metrics:

Grant Date	Shares Awarded	Grant Date Fair Value		Shares Forfeited
December 9, 2021	80,900	$	22.54	4,600
December 7, 2022	89,300	$	23.49	4,600
December 7, 2023	72,200	$	32.15	—

Schedule of Performance Restricted Stock Vesting Conditions

Specifically, the awards vest on a continuum with the following Absolute Total Shareholder Return (A-TSR) milestones:

Vesting Level	Vesting Criteria	Percentage of Award Vested
Level 1	A-TSR greater than or equal to 50%	150%
Level 2	A-TSR less than 50% and greater than or equal to 20%	100%
Level 3	A-TSR less than 20% and greater than or equal to -20%	50%
Level 4	A-TSR less than -20%	—%

Performance Restricted Stock Units by Grant

Grant Date	Shares Awarded	Grant Date Fair Value		Shares Forfeited
December 9, 2021	50,900	$	21.06	3,400
December 7, 2022	51,500	$	23.22	3,100
December 7, 2023	40,700	$	30.35	—

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The following table summarizes amounts expensed as selling, general and administrative expense related to restricted stock awards, stock options, restricted stock units, performance share awards and performance restricted stock units for the three months ended January 31, 2024 and 2023 (in thousands):

	Three Months Ended
	January 31,
	2024		2023
Restricted stock awards	$	317	$	438
Restricted stock units	1,424		1,491
Performance share awards	569		2,639
Performance restricted stock units	266		241
Total compensation expense	$	2,576	$	4,809

Treasury Stock Activity

The following table summarizes the treasury stock activity during the three months ended January 31, 2024:

	Three Months Ended
	January 31, 2024
Beginning Balance as of November 1, 2023	4,165,839
Restricted stock awards granted	(72,900)
Performance restricted stock units vested	(49,228)
Stock options exercised	(20,280)
Balance at January 31, 2024	4,023,431

XML

Segment Information (Tables)

3 Months Ended

Jan. 31, 2024

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment

Segment information for the three months ended January 31, 2024 and 2023, and total assets as of January 31, 2024 and October 31, 2023 are summarized in the following table (in thousands):

	NA Fenestration		EU Fenestration		NA Cabinet Components		Unallocated Corp. & Other		Total
Three Months Ended January 31, 2024
Net sales	$	147,995	$	49,437	$	43,137	$	(1,414)	$	239,155
Depreciation and amortization	5,475		2,558		3,065		54		11,152
Operating income (loss)	8,242		7,431		(3,797)		(3,959)		7,917
Capital expenditures	5,721		1,801		1,836		222		9,580
Three Months Ended January 31, 2023
Net sales	$	152,980	$	54,952	$	54,674	$	(690)	$	261,916
Depreciation and amortization	5,245		2,348		2,934		93		10,620
Operating income (loss)	9,723		7,396		(1,189)		(11,527)		4,403
Capital expenditures	3,613		1,956		1,860		153		7,582
As of January 31, 2024
Total assets	$	372,328	$	242,615	$	156,353	$	42,124	$	813,420
As of October 31, 2023
Total assets	$	379,286	$	239,333	$	158,824	$	53,700	$	831,143

Changes in the Carrying Amount of Goodwill

The change in the carrying amount of goodwill for the three months ended January 31, 2024 was as follows (in thousands):

	Three Months Ended
	January 31, 2024
Beginning balance as of November 1, 2023	$	182,956
Foreign currency translation adjustment	2,483
Balance as of the end of the period	$	185,439

The following table summarizes the change in the carrying amount of goodwill by reportable business segment for the three months ended January 31, 2024 (in thousands):

	NA Fenestration		EU Fenestration		NA Cabinet Comp.		Unallocated Corp. & Other		Total
Balance as of October 31, 2023	$	80,105	$	63,704	$	39,147	$	—	$	182,956
Foreign currency translation adjustment	—		2,483		—		—		2,483
Balance as of January 31, 2024	$	80,105	$	66,187	$	39,147	$	—	$	185,439

Reconciliation of Operating Profit (Loss) from Segments to Consolidated

We did not allocate non-operating loss or income tax benefit to the reportable segments. The following table reconciles operating income as reported above to net income for the three months ended January 31, 2024 and 2023 (in thousands):

	Three Months Ended
	January 31,
	2024		2023
Operating income	$	7,917	$	4,403
Interest expense	(1,068)		(2,259)
Other, net	1,042		218
Income tax expense	(1,642)		(453)
Net income	$	6,249	$	1,909

XML

Earnings Per Share (Tables)

3 Months Ended

Jan. 31, 2024

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted

Basic and diluted earnings per share for the three months ended January 31, 2024 and 2023 were calculated as follows (in thousands, except per share data):

	Net Income		Weighted-Average Shares	Per Share
Three Months Ended January 31, 2024
Basic earnings per common share	$	6,249	32,825	$	0.19
Effect of dilutive securities:
Stock options	—		35	—
Restricted stock awards	—		124	—
Performance restricted stock units	—		59	—
Diluted earnings per common share	$	6,249	33,043	$	0.19
Three Months Ended January 31, 2023
Basic earnings per common share	$	1,909	32,951	$	0.06
Effect of dilutive securities:
Stock options	—		32	—
Restricted stock awards	—		111	—
Performance restricted stock units	—		43	—
Diluted earnings per common share	$	1,909	33,137	$	0.06

XML

Nature of Operations and Basis of Presentation (Details) - USD ($)	3 Months Ended
	Jan. 31, 2024	Jan. 31, 2023
Related Party Transaction [Line Items]
Net sales	$ 239,155,000	$ 261,916,000
Non-employee directors
Related Party Transaction [Line Items]
Net sales	200,000	$ 200,000
Non-employee directors | No single transaction or series of related transactions exceeded $120,000
Related Party Transaction [Line Items]
Net sales	$ 120,000

XML

Nature of Operations and Basis of Presentation Summary of Product Sales (Details) - USD ($) $ in Thousands	3 Months Ended
	Jan. 31, 2024	Jan. 31, 2023
Product Information [Line Items]
Total sales	$ 239,155	$ 261,916
Operating Segments | NA Fenestration
Product Information [Line Items]
Total sales	147,995	152,980
Operating Segments | NA Fenestration | United States | Fenestration [Member]
Product Information [Line Items]
Total sales	111,634	120,767
Operating Segments | NA Fenestration | United States | Non-fenestration [Member]
Product Information [Line Items]
Total sales	25,791	23,066
Operating Segments | NA Fenestration | International | Fenestration [Member]
Product Information [Line Items]
Total sales	6,144	5,127
Operating Segments | NA Fenestration | International | Non-fenestration [Member]
Product Information [Line Items]
Total sales	4,426	4,020
Operating Segments | EU Fenestration
Product Information [Line Items]
Total sales	49,437	54,952
Operating Segments | EU Fenestration | International | Fenestration [Member]
Product Information [Line Items]
Total sales	41,751	42,354
Operating Segments | EU Fenestration | International | Non-fenestration [Member]
Product Information [Line Items]
Total sales	7,686	12,598
Operating Segments | NA Cabinet Components
Product Information [Line Items]
Total sales	43,137	54,674
Operating Segments | NA Cabinet Components | United States | Fenestration [Member]
Product Information [Line Items]
Total sales	3,675	3,908
Operating Segments | NA Cabinet Components | United States | Non-fenestration [Member]
Product Information [Line Items]
Total sales	39,179	50,049
Operating Segments | NA Cabinet Components | International | Non-fenestration [Member]
Product Information [Line Items]
Total sales	283	717
Corporate Non-Segment
Product Information [Line Items]
Total sales	$ (1,414)	$ (690)

XML

Acquisition (Details) $ in Thousands	3 Months Ended		12 Months Ended
	Jan. 31, 2024 USD ($)	Jan. 31, 2023 USD ($)	Oct. 31, 2023 USD ($)	Nov. 01, 2022 ft²
Business Acquisition [Line Items]
Payments to Acquire Businesses, Net of Cash Acquired | $	$ 0	$ 92,000	$ 91,300
OHIO
Business Acquisition [Line Items]
Increase In Net Rentable Area				60,000
Net Rentable Area				313,595

XML

Inventories (Detail) - USD ($) $ in Thousands	Jan. 31, 2024	Oct. 31, 2023
Inventory, Raw Materials and Supplies, Net of Reserves [Abstract]
Raw materials	$ 60,659	$ 53,585
Finished goods and work in process	44,322	42,195
Supplies and other	2,497	2,179
Inventories	$ 107,478	$ 97,959

XML

Goodwill and Intangible Assets - Goodwill (Details)	3 Months Ended
	Jan. 31, 2024 USD ($) reporting_unit
Goodwill and Intangible Assets Disclosure [Abstract]
Number of reporting units | reporting_unit	5
Goodwill, impairment loss	$ 0
Goodwill [Roll Forward]
Beginning balance	182,956,000
Foreign currency translation adjustment	2,483,000
Balance as of the end of the period	$ 185,439,000

XML

Goodwill and Intangible Assets - Identifiable Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Oct. 31, 2023
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	$ 240,341		$ 238,275
Accumulated amortization	168,333		164,160
Intangible assets amortization expense	3,200	$ 3,100
Estimated Amortization Expense
2024 (remaining nine months)	8,540
2025	10,355
2026	10,113
2027	10,114
2028	4,880
Thereafter	28,006
Total	72,008		74,115
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	159,184		157,629
Accumulated amortization	102,324		99,230
Trademarks and trade names
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	56,003		55,519
Accumulated amortization	43,824		42,879
Patents and other technology
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	25,154		25,127
Accumulated amortization	$ 22,185		$ 22,051

XML

Debt and Finance Lease Obligations (Details) - USD ($)		3 Months Ended
	Jul. 06, 2022	Jan. 31, 2024	Jan. 31, 2023	Oct. 31, 2023
Debt Instrument [Line Items]
Unamortized deferred financing fees		$ 1,117,000		$ 1,200,000
Total debt		64,094,000		68,800,000
Current maturities of long-term debt		2,500,000		2,365,000
Long-term Debt		61,594,000		66,435,000
Letters of credit, outstanding		5,100,000
Finance lease obligations and other		55,200,000
Credit Facility, amount available		$ 309,900,000
Debt Instrument, Interest Rate During Period		6.69%	5.43%
Capital Lease Obligations
Debt Instrument [Line Items]
Total debt		$ 55,211,000		55,000,000
Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Revolving Credit Facility		10,000,000
Total debt		$ 10,000,000		$ 15,000,000
Credit Facility [Member]
Debt Instrument [Line Items]
Debt issuance costs	$ (1,200,000)
Debt Instrument, Interest Rate, Stated Percentage		6.68%
Credit Facility [Member] | Line of Credit [Member]
Debt Instrument [Line Items]
Default interest rate		2.00%
Minimum Incremental Borrowing		$ 10,000,000
Maximum Incremental Borrowing		$ 150,000,000
Debt Instrument, Required Coverage Ratio		3.00
Debt Instrument, Required Leverage Ratio		3.25
Debt Instrument, Limitation on Annual Dividend		$ 25,000,000
Debt Instrument, Leverage Ratio Threshold for Limitations to Take Effect		2.75
Debt Instrument, Liquidity Threshold for Limitations to Take Effect		$ 25,000,000
Credit Facility [Member] | Line of Credit [Member] | Less than or equal to 1.50 to 1.00
Debt Instrument [Line Items]
Commitment fee percentage		0.15%
Credit Facility [Member] | Line of Credit [Member] | Greater than 1.50 to 1.00, but less than or equal to 2.25 to 1.00
Debt Instrument [Line Items]
Commitment fee percentage		0.175%
Credit Facility [Member] | Line of Credit [Member] | Greater than 2.25 to 1.00, but less than or equal to 3.00 to 1.00
Debt Instrument [Line Items]
Commitment fee percentage		0.20%
Credit Facility [Member] | Line of Credit [Member] | Greater than 3.00 to 1.00
Debt Instrument [Line Items]
Commitment fee percentage		0.25%
Revolving Credit Facility [Member] | Line of Credit [Member]
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity	$ 325,000,000
Long-Term Debt, Term	5 years
Swing Line [Member] | Line of Credit [Member]
Debt Instrument [Line Items]
Debt Instrument, Unused Borrowing Capacity, Amount		$ 15,000,000
Eurocurrency Rate Loans | Credit Facility [Member] | Line of Credit [Member] | Less than or equal to 1.50 to 1.00
Debt Instrument [Line Items]
Basis spread on variable rate		1.25%
Eurocurrency Rate Loans | Credit Facility [Member] | Line of Credit [Member] | Greater than 1.50 to 1.00, but less than or equal to 2.25 to 1.00
Debt Instrument [Line Items]
Basis spread on variable rate		1.50%
Eurocurrency Rate Loans | Credit Facility [Member] | Line of Credit [Member] | Greater than 2.25 to 1.00, but less than or equal to 3.00 to 1.00
Debt Instrument [Line Items]
Basis spread on variable rate		1.75%
Eurocurrency Rate Loans | Credit Facility [Member] | Line of Credit [Member] | Greater than 3.00 to 1.00
Debt Instrument [Line Items]
Basis spread on variable rate		2.00%
Transitioned RFR Loans | Credit Facility [Member] | Line of Credit [Member] | Less than or equal to 1.50 to 1.00
Debt Instrument [Line Items]
Basis spread on variable rate		1.25%
Transitioned RFR Loans | Credit Facility [Member] | Line of Credit [Member] | Greater than 1.50 to 1.00, but less than or equal to 2.25 to 1.00
Debt Instrument [Line Items]
Basis spread on variable rate		1.50%
Transitioned RFR Loans | Credit Facility [Member] | Line of Credit [Member] | Greater than 2.25 to 1.00, but less than or equal to 3.00 to 1.00
Debt Instrument [Line Items]
Basis spread on variable rate		1.75%
Transitioned RFR Loans | Credit Facility [Member] | Line of Credit [Member] | Greater than 3.00 to 1.00
Debt Instrument [Line Items]
Basis spread on variable rate		2.00%
Base Rate [Member] | Credit Facility [Member] | Line of Credit [Member] | Less than or equal to 1.50 to 1.00
Debt Instrument [Line Items]
Basis spread on variable rate		0.25%
Base Rate [Member] | Credit Facility [Member] | Line of Credit [Member] | Greater than 1.50 to 1.00, but less than or equal to 2.25 to 1.00
Debt Instrument [Line Items]
Basis spread on variable rate		0.50%
Base Rate [Member] | Credit Facility [Member] | Line of Credit [Member] | Greater than 2.25 to 1.00, but less than or equal to 3.00 to 1.00
Debt Instrument [Line Items]
Basis spread on variable rate		0.75%
Base Rate [Member] | Credit Facility [Member] | Line of Credit [Member] | Greater than 3.00 to 1.00
Debt Instrument [Line Items]
Basis spread on variable rate		1.00%

XML

Retirement Plans (Detail) - USD ($) $ in Thousands	3 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Oct. 31, 2023
Retirement Benefits [Abstract]
Supplemental benefit plan liability	$ 2,000		$ 2,000
Deferred compensation liability	4,500		$ 3,900
Net periodic benefit cost:
Service cost	0	$ 96
Interest cost	0	390
Expected return on plan assets	0	(366)
Amortization of net loss	0	10
Settlement reimbursement	(765)	0
Net periodic pension (benefit) cost	$ (765)	$ 130

XML

Income Taxes (Detail) - USD ($) $ in Millions	3 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Oct. 31, 2023
Income Tax Disclosure
Effective Income Tax Rate Reconciliation, Percent	20.80%	19.20%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	21.00%
Effective Income Tax Rate Reconciliation, Vesting or Exercise Of Share-based Payment Arrangement, Amount	$ 0.4
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount	0.6	$ 0.2
Liability for uncertain tax positions	0.3
Valuation allowance	$ 0.6		$ 0.6

XML

Stock Based Compensation (Details) - USD ($) $ in Thousands	3 Months Ended
	Jan. 31, 2024	Jan. 31, 2023
Share-Based Payment Arrangement [Abstract]
Number of shares authorized, originally	3,139,895
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Payment Arrangement, Expense	$ 2,576	$ 4,809
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Payment Arrangement, Expense	317	438
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Payment Arrangement, Expense	1,424	1,491
Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Payment Arrangement, Expense	569	2,639
Performance Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Payment Arrangement, Expense	$ 266	$ 241

XML

Stock-Based Compensation - Restricted Stock Awards (Details) - Restricted Stock Awards (RSAs) - USD ($)	3 Months Ended
	Jan. 31, 2024	Jan. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	3 years
Number of Shares
Non-vested at beginning of the period (in shares)	242,300
Grants (in shares)	72,900
Cancelled (in shares)	(11,800)
Vested (in shares)	(66,600)
Non-vested at end of the period (in shares)	236,800
Weighted-Average Grant Date Fair Value per Share
Non-vested at beginning of the period (in usd per share)	$ 22.36
Granted (in usd per share)	32.15
Cancelled (in usd per share)	22.30
Vested (in usd per share)	20.68
Non-vested at end of the period (in usd per share)	$ 25.85
Fair value of restricted stock awards vested	$ 1,400,000	$ 900,000
Unrecognized compensation cost - non vested restricted stock awards	$ 4,000,000
Weighted-average period over which unrecognized cost is expected to be recognized	2 years 3 months 18 days

XML

Stock-Based Compensation - Stock Options (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Jan. 31, 2024	Jan. 31, 2023
Stock Options, [Roll Forward]
Outstanding at beginning of period (in shares)	107,530
Exercised (in shares)	(20,280)
Outstanding at end of period (in shares)	87,250
Vested (in shares)	87,250
Exercisable at end of period (in shares)	87,250
Weighted-Average Exercise Price
Outstanding at beginning of period (in usd per share)	$ 19.48
Exercised (in usd per share)	19.70
Outstanding at end of period (in usd per share)	19.43
Vested or expected to vest at end of period (in usd per share)	19.43
Exercisable at end of period (in usd per share)	$ 19.43
Weighted Average Remaining Contractual Life
Outstanding, weighted average remaining contractual life	2 years 2 months 12 days
Vested, remaining contractual life	2 years 2 months 12 days
Exercisable, weighted average remaining contractual life	2 years 2 months 12 days
Aggregate Intrinsic Value
Outstanding at end of period	$ 1,028
Vested or expected to vest at end of period	1,028
Exercisable at end of period	$ 1,028
Stock Options
Stock Options, [Roll Forward]
Exercised (in shares)	(20,280)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	3 years
Total intrinsic value of options exercised	$ 200	$ 100

XML

Stock-Based Compensation - Restricted Stock Units (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Jan. 31, 2024	Jan. 31, 2023
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	3 years
Grants (in shares)	26,215	38,704
Granted (in usd per share)	$ 26.70	$ 20.67
Cash paid to settle vested units	$ 100	$ 400
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period	21,774
Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grants (in shares)	49,228

XML

Stock-Based Compensation - Performance Share Awards (Details) - USD ($) $ / shares in Units, $ in Millions				3 Months Ended
	Dec. 07, 2022	Dec. 09, 2021	Dec. 02, 2020	Jan. 31, 2024
Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance shares settled in cash				100.00%
Performance shares granted	72,200	89,300	80,900
Return On Net Assets	$ 32.15	$ 23.49	$ 22.54
Performance shares forfeited	0	4,600	4,600
Vested (in shares)				122,400
Payment For Settlement Of Share-Based Compensation				$ 3.4
Performance Shares | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance shares vesting percentage maximum				0.00%
Performance Shares | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance shares vesting percentage maximum				200.00%
Performance Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance shares granted	40,700	51,500	50,900
Performance shares forfeited	0	3,100	3,400
Vested (in shares)				49,228
Performance Restricted Stock Units | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance shares vesting percentage maximum				0.00%
Performance Restricted Stock Units | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance shares vesting percentage maximum				150.00%

XML

Stock-Based Compensation - Performance Restricted Stock Units (Details) - Performance Restricted Stock Units - $ / shares				3 Months Ended
	Dec. 07, 2022	Dec. 09, 2021	Dec. 02, 2020	Jan. 31, 2024
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period				3 years
Performance restricted stock units settled in cash				100.00%
Performance Restricted Stock Units Granted	40,700	51,500	50,900
Granted (in usd per share)	$ 30.35	$ 23.22	$ 21.06
Performance restricted stock units shares forfeited	0	3,100	3,400
Vested (in shares)				49,228
Performance restricted stock units as probable to vest				58,957
Level 1 [Member] | A-TSR greater than or equal to 50% [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance restricted stock units vesting percentage maximum				150.00%
Level 2 [Member] | A-TSR less than 50% and greater than or equal to 20% [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance restricted stock units vesting percentage maximum				100.00%
Level 3 [Member] | A-TSR less than 20% and greater than or equal to -20% [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance restricted stock units vesting percentage maximum				50.00%
Level 4 [Member] | A-TSR less than -20% [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance restricted stock units vesting percentage maximum				0.00%
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance restricted stock units vesting percentage maximum				0.00%
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance restricted stock units vesting percentage maximum				150.00%

XML

Stock-Based Compensation - Treasury Shares (Details) - shares	3 Months Ended
	Jan. 31, 2024	Oct. 31, 2023
Treasury Stock [Abstract]
Stock options exercised	(20,280)
Treasury stock, common, shares	4,023,431	4,165,839
Restricted Stock Awards (RSAs)
Treasury Stock [Abstract]
Restricted stock awards granted	(72,900)
Performance Shares
Treasury Stock [Abstract]
Restricted stock awards granted	(49,228)
Stock Options
Treasury Stock [Abstract]
Stock options exercised	(20,280)

XML

Segment Information (Details) $ in Millions	3 Months Ended
	Jan. 31, 2024 USD ($) segment	Jan. 31, 2023 USD ($)
Segment Reporting Information [Line Items]
Number of reportable segments	3
Allocated corporate general and administrative expense | $	$ 7.3	$ 4.3
Operating Segments | NA Fenestration
Segment Reporting Information [Line Items]
Number of operating segments	4

XML

Segment Information Segment Reporting Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Oct. 31, 2023
Segment Reporting Information [Line Items]
Net sales	$ 239,155	$ 261,916
Depreciation and amortization	11,152	10,620
Operating income (loss)	7,917	4,403
Capital expenditures	9,580	7,582
Total assets	813,420		$ 831,143
Operating Segments | NA Fenestration
Segment Reporting Information [Line Items]
Net sales	147,995	152,980
Depreciation and amortization	5,475	5,245
Operating income (loss)	8,242	9,723
Capital expenditures	5,721	3,613
Total assets	372,328		379,286
Operating Segments | EU Fenestration
Segment Reporting Information [Line Items]
Net sales	49,437	54,952
Depreciation and amortization	2,558	2,348
Operating income (loss)	7,431	7,396
Capital expenditures	1,801	1,956
Total assets	242,615		239,333
Operating Segments | NA Cabinet Components
Segment Reporting Information [Line Items]
Net sales	43,137	54,674
Depreciation and amortization	3,065	2,934
Operating income (loss)	(3,797)	(1,189)
Capital expenditures	1,836	1,860
Total assets	156,353		158,824
Corporate Non-Segment
Segment Reporting Information [Line Items]
Net sales	(1,414)	(690)
Depreciation and amortization	54	93
Operating income (loss)	(3,959)	(11,527)
Capital expenditures	222	$ 153
Total assets	$ 42,124		$ 53,700

XML

Segment Information Goodwill by Segment (Details) $ in Thousands	3 Months Ended
	Jan. 31, 2024 USD ($)
Goodwill [Line Items]
Beginning balance	$ 182,956
Foreign currency translation adjustment	2,483
Balance as of the end of the period	185,439
Operating Segments | NA Fenestration
Goodwill [Line Items]
Beginning balance	80,105
Foreign currency translation adjustment	0
Balance as of the end of the period	80,105
Operating Segments | EU Fenestration
Goodwill [Line Items]
Beginning balance	63,704
Foreign currency translation adjustment	2,483
Balance as of the end of the period	66,187
Operating Segments | NA Cabinet Components
Goodwill [Line Items]
Beginning balance	39,147
Foreign currency translation adjustment	0
Balance as of the end of the period	39,147
Corporate Non-Segment
Goodwill [Line Items]
Beginning balance	0
Foreign currency translation adjustment	0
Balance as of the end of the period	$ 0

XML

Segment Information Reconciliation of Operating Income to Net Income (Details) - USD ($) $ in Thousands	3 Months Ended
	Jan. 31, 2024	Jan. 31, 2023
Segment Reporting [Abstract]
Operating income	$ 7,917	$ 4,403
Interest expense	(1,068)	(2,259)
Other, net	1,042	218
Income tax expense	(1,642)	(453)
Net income	$ 6,249	$ 1,909

XML

Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Jan. 31, 2024	Jan. 31, 2023
Earnings Per Share Disclosure [Line Items]
Basic earnings per common share	$ 6,249	$ 1,909
Diluted earnings per common share	$ 6,249	$ 1,909
Basic (in shares)	32,825	32,951
Diluted (in shares)	33,043	33,137
Basic earnings per common share	$ 0.19	$ 0.06
Diluted earnings per common share	$ 0.19	$ 0.06
Stock Options
Earnings Per Share Disclosure [Line Items]
Weighted Average Number Diluted Shares Outstanding Adjustment	35	32
Restricted Stock Awards (RSAs)
Earnings Per Share Disclosure [Line Items]
Weighted Average Number Diluted Shares Outstanding Adjustment	124	111
Performance Restricted Stock Units
Earnings Per Share Disclosure [Line Items]
Weighted Average Number Diluted Shares Outstanding Adjustment	59	43